<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Mar Drugs</journal-id><journal-id journal-id-type="iso-abbrev">Mar Drugs</journal-id><journal-id journal-id-type="publisher-id">marinedrugs</journal-id><journal-title-group><journal-title>Marine Drugs</journal-title></journal-title-group><issn pub-type="epub">1660-3397</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6723029</article-id><article-id pub-id-type="doi">10.3390/md17080464</article-id><article-id pub-id-type="publisher-id">marinedrugs-17-00464</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Metabolites from Marine Microorganisms, Micro, and Macroalgae: Immense Scope for Pharmacology</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-9694-9138</contrib-id><name><surname>Barzkar</surname><given-names>Noora</given-names></name><xref ref-type="aff" rid="af1-marinedrugs-17-00464">1</xref><xref rid="c1-marinedrugs-17-00464" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name><surname>Jahromi</surname><given-names>Saeid Tamadoni</given-names></name><xref ref-type="aff" rid="af2-marinedrugs-17-00464">2</xref><xref rid="c1-marinedrugs-17-00464" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name><surname>Poorsaheli</surname><given-names>Hadi Bolooki</given-names></name><xref ref-type="aff" rid="af3-marinedrugs-17-00464">3</xref><xref ref-type="aff" rid="af4-marinedrugs-17-00464">4</xref></contrib><contrib contrib-type="author"><name><surname>Vianello</surname><given-names>Fabio</given-names></name><xref ref-type="aff" rid="af5-marinedrugs-17-00464">5</xref></contrib></contrib-group><aff id="af1-marinedrugs-17-00464"><label>1</label>Department of Marine Biology, Faculty of Marine Science and Technology, University of Hormozgan, Bandar Abbas 74576, Iran</aff><aff id="af2-marinedrugs-17-00464"><label>2</label>Persian Gulf and Oman Sea Ecology Research Center, Iranian Fisheries Sciences Research Institute, Agricultural Research Education and Extension Organization (AREEO), Bandar Abbas 93165, Iran</aff><aff id="af3-marinedrugs-17-00464"><label>3</label>Road, Housing &#x00026; Urban Development Research Center (BHRC), Persian Gulf Branch, Bandar Abbas 93144, Iran</aff><aff id="af4-marinedrugs-17-00464"><label>4</label>Department of Engineering, Islamic Azad University, Bandar Abbas 1696, Iran</aff><aff id="af5-marinedrugs-17-00464"><label>5</label>Department of Comparative Biomedicine and Food Science, University of Padua, viale dell&#x02019;Universit&#x000e0; 16, Legnaro 35020, Italy</aff><author-notes><corresp id="c1-marinedrugs-17-00464"><label>*</label>Correspondence: <email>noora.barzkar@gmail.com</email> or <email>barzkar.phd@hormozgan.ac.ir</email> (N.B); <email>stamadoni@gmail.com</email> (S.T.J.)</corresp></author-notes><pub-date pub-type="epub"><day>08</day><month>8</month><year>2019</year></pub-date><pub-date pub-type="collection"><month>8</month><year>2019</year></pub-date><volume>17</volume><issue>8</issue><elocation-id>464</elocation-id><history><date date-type="received"><day>16</day><month>6</month><year>2019</year></date><date date-type="accepted"><day>27</day><month>7</month><year>2019</year></date></history><permissions><copyright-statement>&#x000a9; 2019 by the authors.</copyright-statement><copyright-year>2019</copyright-year><license license-type="open-access"><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Marine organisms produce a large array of natural products with relevance in drug discovery. These compounds have biological activities such as antioxidant, antibacterial, antitumor, antivirus, anticoagulant, anti-inflammatory, antihypertensive, antidiabetic, and so forth. Consequently, several of the metabolites have made it to the advanced stages of clinical trials, and a few of them are commercially available. In this review, novel information on natural products isolated from marine microorganisms, microalgae, and macroalgae are presented. Given due research impetus, these marine metabolites might emerge as a new wave of promising drugs.</p></abstract><kwd-group><kwd>marine microorganisms</kwd><kwd>natural products</kwd><kwd>pharmaceutical potential</kwd><kwd>bacteria</kwd><kwd>microalgae</kwd><kwd>macroalgae</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-marinedrugs-17-00464"><title>1. Introduction</title><p>Oceans cover about 70% of the earth&#x02019;s surface, serving as the habitat of a great diversity of organisms [<xref rid="B1-marinedrugs-17-00464" ref-type="bibr">1</xref>]. These organisms produce numerous metabolic products. Especially, lower organisms elaborate a multitude of secondary metabolites as signaling molecules for &#x0201c;defense and offense&#x0201d;. These compounds, which belong to diverse chemical classes, can act as potential therapeutics for healthcare [<xref rid="B2-marinedrugs-17-00464" ref-type="bibr">2</xref>]. In the past decades, several promising therapeutics have been extracted from bacteria, fungi, corals, micro- and macroalgae, gorgonians, sponges, nudibranchs, bryozoans, sea cucumbers, tunicates, and sea hares, among other marine organisms [<xref rid="B3-marinedrugs-17-00464" ref-type="bibr">3</xref>]. Considerable efforts have been directed towards the isolation of these compounds, and at the moment, more than 10,000 natural products (NPs) of potential biotechnological interest have been isolated [<xref rid="B4-marinedrugs-17-00464" ref-type="bibr">4</xref>]. The present review reports on the most promising bioactive compounds of marine origin, emphasizing their pharmaceutical potential.</p></sec><sec id="sec2-marinedrugs-17-00464"><title>2. Bioactive NPs from Marine Bacteria and Fungi</title><p>In the marine environment, bacteria and fungi are pervasive. In the past decades, the number of reported bioactive compounds derived from marine bacteria and fungi has steadily increased [<xref rid="B5-marinedrugs-17-00464" ref-type="bibr">5</xref>]. Marine bacteria produce a large repertoire of secondary metabolites to survive in the hostile oceanic conditions. Among others, thermophilic and archaea bacteria elaborate thermostable enzymes which belong to diverse classes [<xref rid="B1-marinedrugs-17-00464" ref-type="bibr">1</xref>,<xref rid="B6-marinedrugs-17-00464" ref-type="bibr">6</xref>].</p><sec id="sec2dot1-marinedrugs-17-00464"><title>2.1. Antibiotic Activity</title><p>The myxomycetes <italic>Lycogala epidendrum</italic> produces halogenated bisindole pyrrole derivatives (Lynamicins A&#x02013;E) (<xref ref-type="fig" rid="marinedrugs-17-00464-f001">Figure 1</xref>A&#x02013;D) with antibacterial activity against <italic>Enterococcus faecalis</italic>, <italic>Staphylococcus epidermidis</italic>, and <italic>Staphylococcus aureus</italic>. Efficacy against these pathogens suggests the potential application of these compounds for the treatment of nosocomial infections [<xref rid="B7-marinedrugs-17-00464" ref-type="bibr">7</xref>]. Similarly, a bacterium isolated from the sea grass <italic>Thalassia</italic> produces a highly brominated pyrrole antibiotic [<xref rid="B8-marinedrugs-17-00464" ref-type="bibr">8</xref>]. The crude extract of <italic>Nocardia</italic> sp. strain, isolated from the marine red marine alga <italic>Laurenica spectabilis,</italic> produces active compounds against bacterial and fungal pathogens [<xref rid="B9-marinedrugs-17-00464" ref-type="bibr">9</xref>]. The eggs of the oriental shrimp <italic>Palaemon macrodactylus</italic> harbor bacterial epibionts with antifungal potential towards the pathogenic fungus <italic>Lagenidium callinectes</italic> [<xref rid="B10-marinedrugs-17-00464" ref-type="bibr">10</xref>]. Likewise, marine fungi have been studied for their bioactive compounds and they have proven to be a valuable source of antibacterial, antibiotic, antifungal, and anticancer compounds [<xref rid="B11-marinedrugs-17-00464" ref-type="bibr">11</xref>]. A marine <italic>Aspergillus</italic> sp. fungus was isolated from the large marine brown alga <italic>Sargassum horneri,</italic> and it produces a polyoxygenated decalin, dehydroxychlorofusarielin B (<xref ref-type="fig" rid="marinedrugs-17-00464-f001">Figure 1</xref>E), which has demonstrated antibacterial activity against methicillin-resistant and multidrug-resistant (MDR) <italic>S. aureus</italic> [<xref rid="B12-marinedrugs-17-00464" ref-type="bibr">12</xref>]. Another fungal <italic>Aspergillus</italic> sp. strain, isolated from a sea fan (<italic>Alcyonacea</italic>), was found to produce antibacterial compounds against <italic>S. aureus</italic> ATCC 25923 and methicillin-resistant <italic>S. aureus</italic> [<xref rid="B13-marinedrugs-17-00464" ref-type="bibr">13</xref>].</p></sec><sec id="sec2dot2-marinedrugs-17-00464"><title>2.2. Anticancer Activity</title><p>Besides antibiotics, marine microorganisms are also a source of anticancer principles. The bacterium <italic>Micromonospora</italic> sp. produces thiocoraline (<xref ref-type="fig" rid="marinedrugs-17-00464-f001">Figure 1</xref>G), a depsipeptide which inhibits cellular DNA polymerase-&#x003b1;. This substance has been applied for the treatment of cancer in preclinical research [<xref rid="B14-marinedrugs-17-00464" ref-type="bibr">14</xref>]. An unidentified fungus of the <italic>Pleosporales</italic> order (strain CRIF2) produces several compounds showing weak cytotoxic activity against tumor cell lines [<xref rid="B15-marinedrugs-17-00464" ref-type="bibr">15</xref>]. A <italic>Pestalotiopsis</italic> sp. fungus, isolated from the leaves of <italic>Rhizophora mucronata,</italic> produces a chromone, namely, pestalotiopsone F (<xref ref-type="fig" rid="marinedrugs-17-00464-f001">Figure 1</xref>H), which displays cytotoxic activity against L5178Y murine cancer cells [<xref rid="B16-marinedrugs-17-00464" ref-type="bibr">16</xref>].</p></sec><sec id="sec2dot3-marinedrugs-17-00464"><title>2.3. Antidiabetic Activity</title><p>Diabetes mellitus (or diabetes) is a debilitating and often life-threatening disorder that is prevalent worldwide, and the number of patients is significantly increasing [<xref rid="B17-marinedrugs-17-00464" ref-type="bibr">17</xref>]. Marine fungi have been screened for possible antidiabetic compounds [<xref rid="B18-marinedrugs-17-00464" ref-type="bibr">18</xref>]. The <italic>Cosmospora</italic> sp. SF-5060 fungus produces aquastatin A (<xref ref-type="fig" rid="marinedrugs-17-00464-f001">Figure 1</xref>F), a secondary metabolite which inhibits protein tyrosine phosphatases 1B (PTP1B) with an effective concentration (EC<sub>50</sub>) value of 0.19 &#x000b5;M. As PTP1B regulates insulin signaling and leptin receptor, aquastatin A might find an application in diabetes management [<xref rid="B18-marinedrugs-17-00464" ref-type="bibr">18</xref>]. Another marine fungus, <italic>Penicillium</italic> sp. JF-55, produces methylethylketone, which exerts inhibitory action on PTP1B as well. Other substances obtained from marine fungi are penstyrylpyrone, anhydrofulvic acid (<xref ref-type="fig" rid="marinedrugs-17-00464-f001">Figure 1</xref>I), and citromycetin (<xref ref-type="fig" rid="marinedrugs-17-00464-f001">Figure 1</xref>J), all displaying inhibitory actions of PTP1B with IC<sub>50</sub> values in the micromolar range [<xref rid="B19-marinedrugs-17-00464" ref-type="bibr">19</xref>].</p><p>Generally, marine bacteria and fungi species survive under hostile conditions, for example, high shear stress, high salinity, high light intensity, and low temperatures, which result in the elaboration of a large array of fascinating and structurally complex molecules. In <xref rid="marinedrugs-17-00464-t001" ref-type="table">Table 1</xref>, some of the bioactive compounds produced by marine fungi and bacteria are listed.</p></sec></sec><sec id="sec3-marinedrugs-17-00464"><title>3. Metabolites with Potential Beneficial Activities from Marine Algae</title><p>Marine algae are the primary producers of oxygen in the aquatic environment and sit at the bottom of the marine food chain, serving all other organisms [<xref rid="B31-marinedrugs-17-00464" ref-type="bibr">31</xref>]. Marine algae can be divided into two main groups: macroalgae (seaweeds) and microalgae, both being prolific sources of bioactive substances [<xref rid="B32-marinedrugs-17-00464" ref-type="bibr">32</xref>]. Therefore, research is in progress for evaluating their medicinal prospects.</p><sec id="sec3dot1-marinedrugs-17-00464"><title>3.1. Marine Microalgae: Blue-Green Algae (Cyanobacteria)</title><p>Marine microalgae typically constitute the phytoplanktons. They can be categorized into three groups: blue-green algae (Cyanobacteria), diatoms (Bacillariophyta), and dinoflagellates (Dinophyceae). There are over 50,000 different species of microalgae, of which only a few have been characterized [<xref rid="B18-marinedrugs-17-00464" ref-type="bibr">18</xref>]. Significant biochemical differences have been found among marine microalgae, resulting in a broad spectrum of novel bioactive compounds [<xref rid="B33-marinedrugs-17-00464" ref-type="bibr">33</xref>] of pharmaceutical interest [<xref rid="B34-marinedrugs-17-00464" ref-type="bibr">34</xref>]. Some of them show high antiviral and anti-HIV activity [<xref rid="B35-marinedrugs-17-00464" ref-type="bibr">35</xref>,<xref rid="B36-marinedrugs-17-00464" ref-type="bibr">36</xref>]. Recently, a new natural anti-AIDS drug has been derived from <italic>Lyngbya lagerhaimanii</italic> and <italic>Phormidium tenue</italic> (<xref rid="marinedrugs-17-00464-t002" ref-type="table">Table 2</xref>). Calcium spirulan isolated from <italic>Spirulina platensis</italic> possesses strong antiviral activity [<xref rid="B37-marinedrugs-17-00464" ref-type="bibr">37</xref>]. Some cyanobacteria strains produce antifouling compounds with antibiotic activity [<xref rid="B38-marinedrugs-17-00464" ref-type="bibr">38</xref>]. For example, the extracts of <italic>Lyngbya majuscule</italic> have been tested as a potential source of antifouling agents [<xref rid="B39-marinedrugs-17-00464" ref-type="bibr">39</xref>]. Some of the cyanobacteria-derived products have multiple properties. For example, ulithiacyclamide and patellamides A and C are known for their antimalarial, antitumor, and MDR-reversing activities [<xref rid="B40-marinedrugs-17-00464" ref-type="bibr">40</xref>]. Two new bioactive compounds, dolastatin 13 (Figure 3C) and lyngbyastatins 5&#x02013;7 (Figure 3D), were isolated from <italic>Lyngbya</italic> spp., which inhibited elastase from porcine pancreas, with an IC<sub>50</sub> = 3&#x02013;10 nM [<xref rid="B41-marinedrugs-17-00464" ref-type="bibr">41</xref>]. Of the three abovementioned groups, cyanobacteria have been credited with the most bioactive compounds. Cyanobacteria (<italic>Cyanophyta</italic>) are a group of Gram-negative bacteria and one of the richest sources of novel bioactive compounds with antifungal, anti-inflammatory, antibiotic, and antitumor activities (<xref rid="marinedrugs-17-00464-t001" ref-type="table">Table 1</xref>), which make them interesting candidates for the production of molecules for new potential pharmaceutical applications [<xref rid="B42-marinedrugs-17-00464" ref-type="bibr">42</xref>].</p><sec id="sec3dot1dot1-marinedrugs-17-00464"><title>3.1.1. Antibiotic Activity</title><p>The antibacterial activity of cyanobacteria might make them useful antibiotics sources. For example, the extracts of <italic>Anabaena variabilis</italic> and <italic>Synechococcus elongates</italic> inhibit the growth of <italic>Escherichia coli</italic>, <italic>Enterococcus</italic>, and <italic>Klebsiella</italic> [<xref rid="B43-marinedrugs-17-00464" ref-type="bibr">43</xref>]. The extracts of <italic>Synechocystis</italic> sp. and <italic>Synechococcus</italic> sp. showed significant antimicrobial activity towards Gram-positive bacteria [<xref rid="B44-marinedrugs-17-00464" ref-type="bibr">44</xref>]. Noscomin (<xref ref-type="fig" rid="marinedrugs-17-00464-f002">Figure 2</xref>C), a diterpenoid, was isolated from <italic>Nostoc commune</italic> and possesses good antibacterial properties [<xref rid="B45-marinedrugs-17-00464" ref-type="bibr">45</xref>]. Other antibiotics are malyngamides (malyngamide D and malyngamide D acetate) and amides of the fatty acid (8)-7(S)-methoxytetradec-4(E)-enoate, isolated from the <italic>L. majuscule</italic> [<xref rid="B46-marinedrugs-17-00464" ref-type="bibr">46</xref>]. Analogously, ambiguine H isonitrile (<xref ref-type="fig" rid="marinedrugs-17-00464-f002">Figure 2</xref>B) and ambiguine I isonitrile are antibiotic alkaloids purified from <italic>Fischerella</italic> sp. [<xref rid="B47-marinedrugs-17-00464" ref-type="bibr">47</xref>]. Another example of an antibacterial compound is kawaguchipeptin B, isolated from the toxin-producing cyanobacterium <italic>Microcystis aeruginosa</italic> [<xref rid="B48-marinedrugs-17-00464" ref-type="bibr">48</xref>].</p></sec><sec id="sec3dot1dot2-marinedrugs-17-00464"><title>3.1.2. Antitumor Activity</title><p>Antitumor compounds affecting cell signaling by the activation of the protein kinase C cascade have been demonstrated in cyanobacteria [<xref rid="B49-marinedrugs-17-00464" ref-type="bibr">49</xref>]. Cyanobacteria elaborate anticancer compounds, such as dolastatin 10 (<xref ref-type="fig" rid="marinedrugs-17-00464-f002">Figure 2</xref>D), curacin A, and cryptophycin (<xref ref-type="fig" rid="marinedrugs-17-00464-f002">Figure 2</xref>A), which target tubulin or actin filaments of eukaryotic cells. Dolastatin 10, a strong microtubule inhibitor that can arrest cell mitotic division, was isolated from <italic>Symploca</italic> sp. [<xref rid="B50-marinedrugs-17-00464" ref-type="bibr">50</xref>]. Curacin A was isolated from <italic>L. majuscule</italic> and is a strong antiproliferative agent, inhibiting microtubule assembly [<xref rid="B51-marinedrugs-17-00464" ref-type="bibr">51</xref>]. Cryptophycin was isolated from marine <italic>Nostoc</italic> sp. GSV 224 and is an anticancer drug candidate with efficacy against L1210 leukemia cells, ovarian carcinoma cells, and drug-resistant breast cancer cells [<xref rid="B52-marinedrugs-17-00464" ref-type="bibr">52</xref>]. The mechanism of action of cryptophycin involves binding at the microtubule ends, leading to the disruption of cell mitosis [<xref rid="B53-marinedrugs-17-00464" ref-type="bibr">53</xref>]. Odoamide is a newly discovered cyclic depsipeptide from <italic>Okeanis</italic> sp., showing strong cytotoxicity against HeLa S3 human cervical cancer cells (IC<sub>50</sub> = 26.3 nM) [<xref rid="B54-marinedrugs-17-00464" ref-type="bibr">54</xref>]. Hierridin B from <italic>Cyanobium</italic> sp. LEGE 06113 exerted cytotoxicity towards HT-29 colon adenocarcinoma cells [<xref rid="B55-marinedrugs-17-00464" ref-type="bibr">55</xref>].</p></sec><sec id="sec3dot1dot3-marinedrugs-17-00464"><title>3.1.3. Antifungal Activity</title><p>Cyanobacteria are important producers of antifungal substances as well, as they are competitors and predators of parasitic fungi. Many antifungal compounds have been isolated from marine extracts of cyanobacteria, including hapalindoles, tolytoxin (<xref ref-type="fig" rid="marinedrugs-17-00464-f003">Figure 3</xref>A), 7-OMe-scytophycin-B, toyocamycin (<xref ref-type="fig" rid="marinedrugs-17-00464-f003">Figure 3</xref>B), tjipanazole D (<xref ref-type="fig" rid="marinedrugs-17-00464-f003">Figure 3</xref>G), hassallidin A, nostocyclamide, and nostodione A (<xref ref-type="fig" rid="marinedrugs-17-00464-f003">Figure 3</xref>F) [<xref rid="B56-marinedrugs-17-00464" ref-type="bibr">56</xref>]. 7-OMe-scytophycin-B, a metabolite isolated from marine <italic>Anabaena</italic> sp. HAN21/1, has shown activity against <italic>Aspergillus flavus</italic> and <italic>Candida albicans</italic> [<xref rid="B57-marinedrugs-17-00464" ref-type="bibr">57</xref>]. A new antifungal lactone compound, majusculoic acid (<xref ref-type="fig" rid="marinedrugs-17-00464-f003">Figure 3</xref>E), has been isolated from a marine cyanobacterial mat community. Majusculoic acid displayed antifungal activity towards <italic>C. albicans</italic> ATCC 14503 [<xref rid="B58-marinedrugs-17-00464" ref-type="bibr">58</xref>]. The butanol extracts of <italic>Spirulina</italic> sp. exhibited antifungal activity against <italic>Candida glabrata</italic> [<xref rid="B59-marinedrugs-17-00464" ref-type="bibr">59</xref>].</p></sec><sec id="sec3dot1dot4-marinedrugs-17-00464"><title>3.1.4. Antimalarial Activity</title><p>Antimalarial activity of natural products isolated from cyanobacteria has been reported. Gademann and Kobylinska (2009) isolated an acyl proline derivative, tumonoic acid I, from <italic>Blennothrix cantharidosmum</italic>, which exhibited moderate toxic activity against <italic>Plasmodium falciparum</italic> (IC<sub>50</sub> = 2 &#x003bc;M) [<xref rid="B60-marinedrugs-17-00464" ref-type="bibr">60</xref>]. Two new antimalarial depsipeptides, companeramides A and B, have been extracted from a marine <italic>Panamanian</italic> cyanobacteria assemblage [<xref rid="B61-marinedrugs-17-00464" ref-type="bibr">61</xref>]. <italic>Oscillatoria nigro-viridis</italic> produces two new linear peptides, viridamides A and B, with antitrypanosomal and antileishmanial activity [<xref rid="B62-marinedrugs-17-00464" ref-type="bibr">62</xref>]. Moreover, cyanobacteria are sources of vitamins B and E [<xref rid="B63-marinedrugs-17-00464" ref-type="bibr">63</xref>]. Pigments extracted from cyanobacteria, such as carotenoids and phycobiliproteins, are already industrially applied as food coloring additives, as supplements for health and fertility of dairy cattle, and in the cosmetics industry.</p></sec><sec id="sec3dot1dot5-marinedrugs-17-00464"><title>3.1.5. Anti-inflammatory Activity</title><p>Cyanobacteria metabolites have also shown pronounced anti-inflammatory effects. For instance, <italic>bis</italic>-bromoindoles from <italic>Rivularia</italic> sp. displayed powerful anti-inflammatory activity [<xref rid="B8-marinedrugs-17-00464" ref-type="bibr">8</xref>]. An anti-inflammatory compound malyngamide F acetate has been derived from <italic>L. majuscule</italic>. This substance inhibited the production of nitric oxide (NO) in stimulated RAW 264.9 cells [<xref rid="B64-marinedrugs-17-00464" ref-type="bibr">64</xref>] by blocking the MyD88 inflammation pathway.</p></sec></sec><sec id="sec3dot2-marinedrugs-17-00464"><title>3.2. Marine Macroalgae</title><p>Macroalgae, or seaweeds, are found in intertidal regions and tropical waters. They are multicellular organisms with various arrays of morphological types and sizes and can be further classified by their photosynthetic pigments into red algae (Rhodophyceae), green algae (Chlorophyceae), and brown algae (Phaeophyceae) [<xref rid="B65-marinedrugs-17-00464" ref-type="bibr">65</xref>]. Currently, over 3200 novel products have been extracted from macroalgae, the majority of which come from subtropical and tropical waters [<xref rid="B66-marinedrugs-17-00464" ref-type="bibr">66</xref>]. Compounds with medical applications, such as antitumor, antioxidant, antiviral, antifouling, anticoagulant, antibacterial, antifungal, and anthelminthic activities, have been detected in macroalgae [<xref rid="B67-marinedrugs-17-00464" ref-type="bibr">67</xref>,<xref rid="B68-marinedrugs-17-00464" ref-type="bibr">68</xref>]. Red seaweeds are proposed as anticoagulants, anthelmintic, and in the treatments of gastritis and diarrhea [<xref rid="B69-marinedrugs-17-00464" ref-type="bibr">69</xref>]. The traditional medical uses of green seaweed spans form anthelmintic to astringent and anti-gout. Brown seaweeds are applied to cure rheumatic diseases, hypertension, arteriosclerosis, menstrual disorders, skin diseases, gastric ulcers, goiter, and syphilis and are also used as anticoagulants. Polysaccharides, such as ulvans from green seaweeds, alginates, fucans, laminarin from brown seaweeds, and carrageenans and porphyrans from red seaweeds, can stimulate defense responses against plant pathogens [<xref rid="B70-marinedrugs-17-00464" ref-type="bibr">70</xref>]. Thus, marine algae yield a large diversity of bioactive metabolites and appear to be a potential resource of interesting pharmacological substances. The sections below present the therapeutic compounds and functions of members from each of the three groups of seaweeds.</p><sec id="sec3dot2dot1-marinedrugs-17-00464"><title>3.2.1. Red Seaweeds</title><p>Red seaweeds are commonly considered beneficial for human health and an important source of bioactive compounds [<xref rid="B86-marinedrugs-17-00464" ref-type="bibr">86</xref>]. For centuries, their extracts have been applied for the cure of asthma, thyroid goiter, urinary infections, stomach ulcers, and even tumors. Among the compounds isolated from red seaweeds, sulfated polysaccharides are economically the most important bioactive compound because of their wide application in medicine. These polysaccharides are carrageenan, agar (<xref ref-type="fig" rid="marinedrugs-17-00464-f004">Figure 4</xref>A), agarose, and furcellaran (Danish agar). Carrageenan is produced by the genera <italic>Chondrus, Eucheuma, Gigartina</italic>, and <italic>Iridea</italic> and is considered an effective remedy for gastric and duodenal ulcers [<xref rid="B87-marinedrugs-17-00464" ref-type="bibr">87</xref>]. <italic>Chondrus crispus</italic> is a good source of carrageenan that has an antiviral property, in particular against influenza B and mumps virus [<xref rid="B88-marinedrugs-17-00464" ref-type="bibr">88</xref>]. Agar and agarose are used for interferon production, usage as antiviral compounds, and improving B- and T-cell activity [<xref rid="B89-marinedrugs-17-00464" ref-type="bibr">89</xref>]. A polysaccharide (Mw = 100&#x02013;500 kDa) isolated from the fermented red seaweed <italic>Lomentaria catenata</italic> possesses anticoagulant activity [<xref rid="B90-marinedrugs-17-00464" ref-type="bibr">90</xref>]. Fucoidan (<xref ref-type="fig" rid="marinedrugs-17-00464-f004">Figure 4</xref>F), extracted from <italic>Gracilaria corticata,</italic> showed activity against both colorectal and breast cancer [<xref rid="B91-marinedrugs-17-00464" ref-type="bibr">91</xref>]. An anthelmintic compound, L-&#x003b1;-kainic acid (<xref ref-type="fig" rid="marinedrugs-17-00464-f004">Figure 4</xref>B), has been isolated from <italic>Digenea simplex</italic> [<xref rid="B92-marinedrugs-17-00464" ref-type="bibr">92</xref>]. Deepa et al. (2017) reported on the possible effects of <italic>G. corticata</italic> on cancer treatments, inflammation, and infectious diseases [<xref rid="B91-marinedrugs-17-00464" ref-type="bibr">91</xref>]. Some red seaweeds, such as <italic>Rhodomela confervoides, Symphyocladia latiuscula</italic>, and <italic>Polysiphonia urceolata,</italic> produce phenolic compounds, which have shown antidiabetic activity. These compounds possess the capacity to inhibit protein tyrosine phosphatase (PTPase), which is responsible for the response to insulin. Collins reported on the antiasthmatic activity of polyphenolic extracts of <italic>Laurencia undulate</italic> [<xref rid="B68-marinedrugs-17-00464" ref-type="bibr">68</xref>]. A new potent inhibitor of lipoxygenase (LOX), which plays a crucial role in neurodegeneration, has been isolated from <italic>Odonthalia corymbifera</italic> [<xref rid="B93-marinedrugs-17-00464" ref-type="bibr">93</xref>]. The substance is pheophytin A, which can be applied as a new therapeutic, and is considered an excellent opportunity for the treatment of neuropathologies such as Alzheimer&#x02019;s disease.</p><sec><title>Antiviral Activity</title><p>Witvrouw et al. (1994) isolated a polysaccharide, galactan sulfate, from <italic>Agardhiella tenera</italic> that showed activity against HIV-1 and HIV-2, with IC<sub>50</sub> values of 0.5 and 0.05 &#x003bc;g/L, respectively [<xref rid="B94-marinedrugs-17-00464" ref-type="bibr">94</xref>]. Devi et al. reported on the antioxidant and antimicrobial activity of the methanolic extracts of different Indian red seaweeds [<xref rid="B95-marinedrugs-17-00464" ref-type="bibr">95</xref>]. An antiviral compound, sulfated xylomannan, has been extracted from the Indian red seaweed <italic>Scinaia hatei</italic> that inhibited HSV-1 and HSV-2 (IC<sub>50</sub> = 0.5&#x02013;1.4 &#x003bc;g/mL) [<xref rid="B96-marinedrugs-17-00464" ref-type="bibr">96</xref>]. Water-soluble polysaccharidic extracts of <italic>Sphaerococcus coronopifolius</italic> and <italic>Boergeseniella thuyoides</italic> collected from the coast of Morocco showed antiviral properties against viruses, including HIV and HSV-1 [<xref rid="B97-marinedrugs-17-00464" ref-type="bibr">97</xref>]. Serkedjieva (2004) extracted a bioactive compound from <italic>Ceramium rubrum</italic> isolated from the Black Sea. This metabolite inhibited types A and B influenza viruses, both in vivo and in vitro, followed by the reduction of cytopathogenic effects [<xref rid="B98-marinedrugs-17-00464" ref-type="bibr">98</xref>].</p></sec><sec><title>Antioxidant Activity</title><p>Antioxidant properties has been found in several species of red seaweeds, including <italic>Gracilaria, Halymenia, Laurencia, Ahnfeltiopsis</italic>, and <italic>Polysiphonia</italic>. For example, mycosporine-like amino acids isolated from <italic>Ahnfeltiopsis devoniensis</italic> show antioxidant activity [<xref rid="B99-marinedrugs-17-00464" ref-type="bibr">99</xref>]. Moreover, two classes of natural compounds, polyphenols and bromophenols, with known antioxidant activity were isolated from red seaweeds [<xref rid="B100-marinedrugs-17-00464" ref-type="bibr">100</xref>]. The ethanolic [<xref rid="B101-marinedrugs-17-00464" ref-type="bibr">101</xref>] and methanolic [<xref rid="B102-marinedrugs-17-00464" ref-type="bibr">102</xref>] extracts isolated from <italic>Gracilaria tenuistipitata</italic> showed antiproliferative activity on the oral carcinoma cell line <italic>Ca 9-22</italic> by modulating oxidative-stress-induced cell apoptosis.</p></sec><sec><title>Antibiotic Activity</title><p>Rahelivao reported on the properties of crude extracts of the red algae <italic>Laurencia complanata,</italic> which displayed antibacterial activity against <italic>Streptococcus pneumoniae, Bacillus cereus</italic>, and <italic>S. aureus</italic> [<xref rid="B81-marinedrugs-17-00464" ref-type="bibr">81</xref>]. Four tetracyclic brominated 1, 4-diterpenes were isolated from the extract of <italic>S. coronopifolius</italic>, collected from the rocky coasts of Corfu Island (Greece). These diterpenes showed antibiotic activity against a panel of bacteria, including methicillin-resistant <italic>S. aureus</italic> (MRSA) and MDR strains, with MIC (Minimum Inhibitory Concentrations) values in the 16&#x02013;128 &#x000b5;g/mL range [<xref rid="B103-marinedrugs-17-00464" ref-type="bibr">103</xref>]. Crude methanolic extracts isolated from <italic>Acanthaphora spicifera</italic> showed antibacterial activity against <italic>E. coli</italic>, <italic>Bacillus subtilis</italic>, <italic>Pseudomonas aeruginosa</italic>, and <italic>Bacillus palmitus</italic> [<xref rid="B104-marinedrugs-17-00464" ref-type="bibr">104</xref>]. Also, antifungal activity of the extracts against <italic>C. albicans</italic>, <italic>Aspergillus niger</italic>, and <italic>Microsporum gypseum</italic> was observed [<xref rid="B105-marinedrugs-17-00464" ref-type="bibr">105</xref>].</p></sec><sec><title>Antitumor and Anticoagulant Activities</title><p>A novel polyhalogenated monoterpene, halomon, isolated from <italic>Portieria hornemannii</italic>, shows cytotoxic action against numerous human tumor cell lines (brain, kidney, and colon) and is currently in the preclinical testing phase [<xref rid="B106-marinedrugs-17-00464" ref-type="bibr">106</xref>]. Moreover, Andrianasolo (2006) isolated three halomon derivatives from <italic>P. hornemannii</italic>, which exhibited inhibitory effects on the DNA methyltransferase-1 enzyme [<xref rid="B107-marinedrugs-17-00464" ref-type="bibr">107</xref>]. Among other functions, DNA methyltransferase has a profound role in epigenetics and gene expression. The anticoagulant activity of sulfated polysaccharides derived from <italic>Delesseria sanguinea</italic> (<italic>Ceramiales</italic>) [<xref rid="B108-marinedrugs-17-00464" ref-type="bibr">108</xref>] and a sulfated galactan fraction from <italic>Botryocladia occidentalis</italic> (<italic>Rhodymeniales</italic>) was reported [<xref rid="B109-marinedrugs-17-00464" ref-type="bibr">109</xref>]. Matsuhiro et al. (2005) reported on an antiviral sulfated galactan from <italic>Schizymenia binderi</italic> [<xref rid="B110-marinedrugs-17-00464" ref-type="bibr">110</xref>]. Moreover, <italic>Botryocladia leptopoda</italic> extracts exhibited stimulant activities on the central nervous system (CNS) in a mouse model [<xref rid="B111-marinedrugs-17-00464" ref-type="bibr">111</xref>].</p></sec></sec><sec id="sec3dot2dot2-marinedrugs-17-00464"><title>3.2.2. Brown Seaweeds</title><p>Brown seaweeds contain several pigments, such as fucoxanthin, violaxanthin, and &#x003b2;-carotene [<xref rid="B112-marinedrugs-17-00464" ref-type="bibr">112</xref>]. Fucoxanthin occurs in edible marine brown algae, including <italic>Undaria pinnatifida</italic>, <italic>Laminaria japonica, Sargassum fulvellum</italic>, and <italic>Hijikia fusiformis</italic>, and possesses antioxidant, anticancer, antiobesity, antidiabetic, and antiphotoaging activities [<xref rid="B113-marinedrugs-17-00464" ref-type="bibr">113</xref>]. The ethanolic extract of <italic>Turbinaria conoides</italic> demonstrated antioxidant, antibacterial, and anticancer properties. The sources and properties of some bioactive principles in the extracts of brown seaweeds are reported in <xref rid="marinedrugs-17-00464-t002" ref-type="table">Table 2</xref>. For example, organic solvent extracts from <italic>Sargassum wightii</italic> and <italic>Sargassum ilicifolium</italic> exhibited an interesting anticancer activity on several cells lines [<xref rid="B114-marinedrugs-17-00464" ref-type="bibr">114</xref>]. Several studies on <italic>U. pinnatifida</italic> demonstrated anti-hyperglycemic, antitumor, anti-hypertensive, and antiobesity potential [<xref rid="B115-marinedrugs-17-00464" ref-type="bibr">115</xref>]. Khan reported on an omega-3 essential fatty acid, stearidonic acid, isolated from <italic>U. pinnatifida</italic> which showed activity against erythema, mouse ear inflammation, edema, and blood flows (IC<sub>50</sub> = 160, 314, and 235 &#x003bc;g/per ear, respectively) [<xref rid="B116-marinedrugs-17-00464" ref-type="bibr">116</xref>]. Laminarin is a water-soluble polysaccharide found in brown algae that has strong heparin-like activity and, therefore, is useful as an anticoagulant, antilipemic, antiviral, or anti-inflammatory agent [<xref rid="B17-marinedrugs-17-00464" ref-type="bibr">17</xref>]. Park et al. (2011) reported that that fucoidan reduces lipid accumulation by stimulating lipolysis, and it can be beneficial for obesity therapy [<xref rid="B117-marinedrugs-17-00464" ref-type="bibr">117</xref>]. Spavieri reported on the antimycobacterial, antiprotozoal, and cytotoxic activity of 21 brown algae (<italic>Phaeophyceae</italic>) from British and Irish waters [<xref rid="B118-marinedrugs-17-00464" ref-type="bibr">118</xref>]. Several other bioactive compounds were reported for fucoidans isolated from different species of brown algae, including antiviral and antibacterial activities [<xref rid="B119-marinedrugs-17-00464" ref-type="bibr">119</xref>]. Moreover, fucoidans isolated from brown seaweed species present immunomodulating activity, involving the increased generation of macrophage-mediated responses such as interleukin-2 (IL-2), interleukin-12 (IL-12), and interferon gamma (IFN-&#x003b3;) [<xref rid="B120-marinedrugs-17-00464" ref-type="bibr">120</xref>]. Salgado reported on the interactions between polyphenolic compounds from the brown alga <italic>Padina gymnospora</italic> and cell wall alginates, leading to the absorption of ultraviolet radiation [<xref rid="B121-marinedrugs-17-00464" ref-type="bibr">121</xref>]. Also, diekol isolated from <italic>Ecklonia cava</italic> showed antifungal, anti-inflammatory, and anti-type-II diabetes activities in mouse models [<xref rid="B122-marinedrugs-17-00464" ref-type="bibr">122</xref>].</p><sec><title>Antibacterial and Antioxidant Activities</title><p>The essential oil derived from <italic>U. pinnatifida</italic> possesses potent antibacterial and antioxidant activities [<xref rid="B114-marinedrugs-17-00464" ref-type="bibr">114</xref>]. The methanolic extracts of <italic>Sargassum platycarpum</italic> A and <italic>Sargassum latifolium</italic> B were shown to be highly effective against Gram-positive bacteria [<xref rid="B123-marinedrugs-17-00464" ref-type="bibr">123</xref>]. Three novel products from <italic>Ecklonia maxima</italic>&#x02014;eckol, dibenzo-dioxine-2,4,7,9-tetraol, and phloroglucinol&#x02014;were shown to exhibit free-radical scavenging activity by a DPPH assay, and the EC<sub>50</sub> values were 0.008, 0.012, and 0.128 &#x003bc;M, respectively [<xref rid="B124-marinedrugs-17-00464" ref-type="bibr">124</xref>]. The phenolic extracts of <italic>Sargassum</italic> showed antibacterial and antioxidant properties [<xref rid="B125-marinedrugs-17-00464" ref-type="bibr">125</xref>].</p></sec><sec><title>Antidepressant Activity</title><p>Extracts of <italic>Sargassum swartzii</italic> and <italic>Stoechospermum marginatum</italic> showed significant stimulant and anxiolytic effects on a rat model, which occurred by the amelioration of brain norepinephrine levels [<xref rid="B126-marinedrugs-17-00464" ref-type="bibr">126</xref>]. The aqueous extracts of <italic>Cystoseira usneoides, Cystoseira tamarascifolia, Cystoseira nodicaulis, Stypocaulon scoparium,</italic> and <italic>Fucus spiralis</italic> showed antidepressant activity by inhibiting the monoamine oxidase A (MAO-A) enzyme [<xref rid="B127-marinedrugs-17-00464" ref-type="bibr">127</xref>].</p></sec><sec><title>Anticancer Activity</title><p>A cytotoxic metabolite, stypoldione, isolated from <italic>Stypodium zonale</italic> inhibited microtubule polymerization, thereby preventing mitotic spindle formation in cell cultures [<xref rid="B128-marinedrugs-17-00464" ref-type="bibr">128</xref>]. Ethanolic extracts of <italic>U. pinnatifida</italic> sporophylls induced nonoxidative apoptotic damage on human colon or rectum cancer cells [<xref rid="B129-marinedrugs-17-00464" ref-type="bibr">129</xref>]. The derivative of atomaric acid, stypoquinonic acid (<xref ref-type="fig" rid="marinedrugs-17-00464-f004">Figure 4</xref>C), isolated from <italic>S. zonale</italic> is an inhibitor of the tyrosine kinase enzyme. Another atomaric acid derivative, dimethoxy-atomaric acid, showed cytotoxic activity against lung and colon cancer cells [<xref rid="B130-marinedrugs-17-00464" ref-type="bibr">130</xref>]. Moreover, fucoidan is known to possess other bioactive properties, such as inhibitory effects on the growth of cancer cells [<xref rid="B131-marinedrugs-17-00464" ref-type="bibr">131</xref>]. Sodium alginate (<xref ref-type="fig" rid="marinedrugs-17-00464-f004">Figure 4</xref>J) obtained from brown seaweeds has shown antitumor and anti-inflammatory properties [<xref rid="B132-marinedrugs-17-00464" ref-type="bibr">132</xref>]. The anticancer activity was evaluated by analyzing the effects on the cell cycle and apoptosis induction on HepG2 cells [<xref rid="B133-marinedrugs-17-00464" ref-type="bibr">133</xref>]. Furthermore, several studies validated the apoptosis induction ability of fucoidans in various tumor cell lines, including melanoma cells, colon cancer, lymphoma, and breast cancer cells [<xref rid="B134-marinedrugs-17-00464" ref-type="bibr">134</xref>].</p></sec><sec><title>Antiangiogenic and Anticoagulant Activities</title><p>Phlorofucofuroeckol A (<xref ref-type="fig" rid="marinedrugs-17-00464-f004">Figure 4</xref>I), a phlorotannin (<xref ref-type="fig" rid="marinedrugs-17-00464-f004">Figure 4</xref>H) from <italic>Ecklonia kurome</italic>, exhibited inhibitory activity on the angiotensin-converting enzyme, with an IC<sub>50</sub> value of 12.74 &#x000b5;M [<xref rid="B135-marinedrugs-17-00464" ref-type="bibr">135</xref>]. The sulfated polysaccharides known as fucoidans caused the prevention of cell proliferation and migration and also vascular network formation on human umbilical vein endothelial cells (<italic>HUVEC),</italic> suggesting significant antiangiogenic activity [<xref rid="B136-marinedrugs-17-00464" ref-type="bibr">136</xref>]. Remarkably, this effect deteriorated upon the reduction of fucoidan molecular weight (&#x0003c;30 kDa) [<xref rid="B137-marinedrugs-17-00464" ref-type="bibr">137</xref>]. An analogous observation was reported for the anticoagulant activities of fucoidans [<xref rid="B138-marinedrugs-17-00464" ref-type="bibr">138</xref>]. A fucoidan isolated from <italic>Fucus vesiculosus</italic> showed antithrombotic activity [<xref rid="B139-marinedrugs-17-00464" ref-type="bibr">139</xref>].</p></sec><sec><title>Antiviral Activity</title><p>Phlorotannin derivatives extracted from <italic>E. cava</italic>, 8,4&#x02032;-dieckol and 8,8&#x02032;-bieckol (<xref ref-type="fig" rid="marinedrugs-17-00464-f004">Figure 4</xref>G), displayed an anti-HIV-1 property by inhibiting the viral reverse transcriptase and the protease at concentrations (IC<sub>50</sub>) of 5.3 and 0.5 &#x003bc;M, respectively [<xref rid="B140-marinedrugs-17-00464" ref-type="bibr">140</xref>]. Hayashi et al. studied the fucoidan from <italic>U. pinnatifida</italic> and described its defensive effects against herpes simplex virus (HSV) infections [<xref rid="B141-marinedrugs-17-00464" ref-type="bibr">141</xref>]. Also, Queiroz reported on a brown seaweed polysaccharide inhibiting the activity of the reverse transcriptase of HIV [<xref rid="B142-marinedrugs-17-00464" ref-type="bibr">142</xref>]. Fucans from <italic>Dictyota mertensii</italic>, <italic>F. vesiculosus</italic>, <italic>Spatoglossum schroederi</italic>, and <italic>Lobophora variegate</italic> show inhibitory effects on the reverse transcriptase of HIV-1 [<xref rid="B143-marinedrugs-17-00464" ref-type="bibr">143</xref>].</p></sec><sec><title>Antiparasitic Activity</title><p>Soares demonstrated that brown algae belonging to the family of <italic>Dictyotaceae</italic>, namely <italic>Dictyota pfaffii</italic> and <italic>Canistrocarpus cervicornis,</italic> possess antileishmania activity [<xref rid="B144-marinedrugs-17-00464" ref-type="bibr">144</xref>]. Nara reported that the extracts from <italic>Pelvetia babingtonii</italic> and <italic>Fucus evanescens</italic> contain inhibitors of dihydroorotate dehydrogenase, a virulence agent of <italic>Trypanosoma cruzi</italic>, the protozoa responsible of the Chagas disease [<xref rid="B145-marinedrugs-17-00464" ref-type="bibr">145</xref>]. Dolabelladienetriol, a diterpene derived from <italic>D. pfaffii,</italic> showed killing effects against <italic>Leishmania</italic> intracellular amastigotes (IC<sub>50</sub> = 44 &#x000b5;M) as well as anti-HIV-1 activities [<xref rid="B146-marinedrugs-17-00464" ref-type="bibr">146</xref>]. Eleganolone (<xref ref-type="fig" rid="marinedrugs-17-00464-f003">Figure 3</xref>), another diterpene from <italic>Bifurcaria bifurcate,</italic> exerted strong inhibitory activity (IC<sub>50</sub> = 0.53 &#x000b5;g/mL) against the bloodstream forms of <italic>Trypanosoma brucei rhodesiense</italic> [<xref rid="B147-marinedrugs-17-00464" ref-type="bibr">147</xref>].</p><p>Of course, the clinical application of all these substances depends on further studies and safety evaluations.</p></sec></sec><sec id="sec3dot2dot3-marinedrugs-17-00464"><title>3.2.3. Green Seaweeds</title><p>Green seaweeds, or <italic>chlorophyta</italic>, are a large group of macroalgae with worldwide distribution. The morphology of some species is presented in <xref ref-type="fig" rid="marinedrugs-17-00464-f003">Figure 3</xref>. Green seaweeds are highly considered for their production of antioxidants, vitamins, and bioactive peptides [<xref rid="B148-marinedrugs-17-00464" ref-type="bibr">148</xref>]. Among their bioactive constituents, cell wall polysaccharides, constituting about 38&#x02013;54% of the seaweed dry matter, show pharmaceutical potential [<xref rid="B149-marinedrugs-17-00464" ref-type="bibr">149</xref>]. Some green seaweeds, such as <italic>Caulerpa taxifolia</italic>, <italic>Caulerpa racemose</italic>, and <italic>Cladophora pinnulata</italic>, show hypotensive activities [<xref rid="B111-marinedrugs-17-00464" ref-type="bibr">111</xref>]. At the moment, most of the literature on green seaweed products is focused on sulfated polysaccharides because of their interesting properties, including anticoagulant, antioxidant, anticancer, anti-hyperlipidemic, and immunomodulation effects [<xref rid="B150-marinedrugs-17-00464" ref-type="bibr">150</xref>]. Ulvan, a sulfated polysaccharide form <italic>Ulva pertusa</italic>, has valuable antioxidant activity [<xref rid="B151-marinedrugs-17-00464" ref-type="bibr">151</xref>]. It also acts on the plasma levels of low-density lipoprotein (LDL), high-density lipoprotein (HDL), and triglycerides in mice and can be useful for ischemic, cerebrovascular, and cardiovascular diseases [<xref rid="B152-marinedrugs-17-00464" ref-type="bibr">152</xref>]. Sulfated polysaccharides from <italic>U. pertusa</italic>, <italic>Capsosiphon fulvescens,</italic> and <italic>Codium fragile</italic> possess potent immune-modulating activity by stimulating macrophages [<xref rid="B153-marinedrugs-17-00464" ref-type="bibr">153</xref>]. Also, the ethanolic extracts of <italic>Codium tomentosum</italic> showed antigenotoxic and antioxidant effects [<xref rid="B154-marinedrugs-17-00464" ref-type="bibr">154</xref>] and <italic>Codium decorticatum</italic> showed antibacterial activity [<xref rid="B155-marinedrugs-17-00464" ref-type="bibr">155</xref>]. Moreover, methanolic extracts of <italic>Ulva linza,</italic> due to their high polyunsaturated fatty acids (PUFA) content, showed high inhibitory activity against inflammatory response [<xref rid="B156-marinedrugs-17-00464" ref-type="bibr">156</xref>].</p><sec><title>Antiviral Activity</title><p>Sulfated polysaccharides from nine different green seaweeds (<italic>Caulerpa brachypus</italic>, <italic>Caulerpa scapelliformis</italic>, <italic>Caulerpa okamurai</italic>, <italic>Chaetomorpha crassa</italic>, <italic>Chaetomorpha spiralis</italic>, <italic>Monostroma nitidum</italic>, <italic>C. fragile</italic>, <italic>Codium adhaerens</italic>, and <italic>Codium latum</italic>) exhibited strong activity against type 1 herpes virus, with the IC<sub>50</sub> ranging from 0.38 to 8.5 &#x000b5;g/mL, while presenting low cytotoxicity [<xref rid="B157-marinedrugs-17-00464" ref-type="bibr">157</xref>]. Rhamnan sulfate, another sulfated polysaccharide from <italic>M. nitidum</italic>, was effective against type 2 herpes virus by inhibiting its adsorption and penetration onto host cells [<xref rid="B78-marinedrugs-17-00464" ref-type="bibr">78</xref>]. In a study carried out by Sato et al. (2011), a high-mannose-binding lectin was isolated from <italic>Boodlea coacta</italic>. This lectin showed antiviral activity against HIV-1 infections (EC<sub>50</sub>
<italic>=</italic> 8.2 nM) and influenza viruses [<xref rid="B158-marinedrugs-17-00464" ref-type="bibr">158</xref>]. The potent anti-HIV-1 activity was related to the carbohydrate-binding tendency, formerly reported for other antiviral lectins. In addition, ethanolic extracts of <italic>Codium elongatum</italic> and <italic>Ulva fasciata</italic> exhibited antiviral activity against the <italic>Semliki forest</italic> and <italic>Vaccinia</italic> viruses [<xref rid="B111-marinedrugs-17-00464" ref-type="bibr">111</xref>].</p></sec><sec><title>Antioxidant and Anticancer Activities</title><p>According to Wang, extracts and monounsaturated fatty acids (MUFA) derivatives from <italic>Ulva lactuca</italic> induced an antioxidant response in cells [<xref rid="B159-marinedrugs-17-00464" ref-type="bibr">159</xref>]. Beta-carotene is a potent antioxidant found in green seaweeds and can be accumulated in very high amounts in <italic>Dunaliella salina</italic> [<xref rid="B160-marinedrugs-17-00464" ref-type="bibr">160</xref>]. Carotenoids, for example, lutein (<xref ref-type="fig" rid="marinedrugs-17-00464-f004">Figure 4</xref>E) and zeaxanthin from the green seaweed <italic>Chlorococcum humicola</italic>, exhibited antimutagenic activity against benzo[<italic>a</italic>]pyrene-induced mutations in histidine-revertant cells of <italic>Salmonella typhimurium</italic> and were proposed for the reduction of the breast cancer risks [<xref rid="B161-marinedrugs-17-00464" ref-type="bibr">161</xref>]. Another carotenoid from green seaweeds, siphonaxanthin (<xref ref-type="fig" rid="marinedrugs-17-00464-f004">Figure 4</xref>D), effectively induced apoptosis in human leukemia (HL-60) cells by caspase-3 activation, accompanied by the modification of growth arrest and DNA-damage-inducible protein (GADD45&#x003b1;), tumor necrosis factor receptors (DR5/TRAIL receptor-2), and Bcl-2 regulatory protein expression pattern [<xref rid="B162-marinedrugs-17-00464" ref-type="bibr">162</xref>]. Ganesan reported that siphonaxanthin derived from <italic>C. fragile</italic> possesses considerable antiangiogenic activity [<xref rid="B163-marinedrugs-17-00464" ref-type="bibr">163</xref>]. Moreover, the ethanolic extracts of <italic>C. tomentosum</italic> showed antigenotoxic and antioxidant effects [<xref rid="B154-marinedrugs-17-00464" ref-type="bibr">154</xref>].</p></sec><sec><title>Antibacterial and Antifouling Activities</title><p>Extracts of <italic>U. fasciata</italic> isolated from the southeast coast of India displayed antibacterial properties and a broad spectrum of antibiotic activity against <italic>B. cereus</italic>, <italic>E. coli</italic>, <italic>B. subtilis</italic>, <italic>Aeromonas hydrophila</italic>, <italic>Vibrio fischeri</italic>, and <italic>Vibrio harveyi</italic> [<xref rid="B164-marinedrugs-17-00464" ref-type="bibr">164</xref>]. <italic>Cladophora glomerata</italic> exhibited significant antibacterial activity against the MDR bacterium <italic>Acinetobacter baumannii</italic> and various human and fish pathogens, such as <italic>E. coli</italic>, <italic>B. cereus</italic>, <italic>Vibrio anguillarum</italic>, <italic>V. fischeri, Vibrio parahaemolyticus</italic>, and <italic>Vibrio vulnificus</italic> [<xref rid="B165-marinedrugs-17-00464" ref-type="bibr">165</xref>]. An acetylenic sesquiterpene isolated from <italic>Caulerpa prolifera</italic>, caulerpenyne (<xref ref-type="fig" rid="marinedrugs-17-00464-f004">Figure 4</xref>H), exhibited antifouling activity against bacteria and the microalga <italic>Phaeodactylum tricornutum</italic> [<xref rid="B166-marinedrugs-17-00464" ref-type="bibr">166</xref>]. Moreover, the ethanolic extracts of <italic>C. decorticatum</italic> showed antibacterial activity [<xref rid="B155-marinedrugs-17-00464" ref-type="bibr">155</xref>]</p></sec><sec><title>Anticoagulant Activity</title><p>The earliest report on the anticoagulant effects of substances produced by green seaweeds were carried out on <italic>Codium</italic>, in particular on <italic>C. fragile</italic> ssp. <italic>tomentosoides</italic> [<xref rid="B167-marinedrugs-17-00464" ref-type="bibr">167</xref>]. Matsubara also reported on the anticoagulant activity of a sulfated galactan in the <italic>Codium</italic> genus [<xref rid="B168-marinedrugs-17-00464" ref-type="bibr">168</xref>]. Furthermore, Maeda described that sulfated polysaccharides from the marine green alga <italic>M. nitidum</italic> yielded a sixfold higher anticoagulant effect than heparin [<xref rid="B169-marinedrugs-17-00464" ref-type="bibr">169</xref>]. Also, Synytsya reported on the anticoagulant activity of sulfated polysaccharides derived from <italic>C. fulvescens</italic> [<xref rid="B170-marinedrugs-17-00464" ref-type="bibr">170</xref>].</p><p>The findings presented above suggest that green marine algae can be considered a promising source of bioactive substances, which should be further studied and exploited for pharmaceutical applications. Some of the biological activities of compounds extracted from marine seaweeds are presented in <xref rid="marinedrugs-17-00464-t002" ref-type="table">Table 2</xref>.</p></sec></sec></sec></sec><sec id="sec4-marinedrugs-17-00464"><title>4. Concluding Remarks</title><p>The marine environment represents a unique source of bioactive compounds with high pharmaceutical potential. Preclinical and clinical studies are in progress for a number of marine organism derivatives. Nevertheless, several problems should be solved for a deep characterization of biomolecules derived from marine microorganisms, micro, and macroalgae. Notably, marine microbes are notoriously difficult to prepare and maintain in culture. Bacteria likely grow as consortia in the marine environment and dependences on other bacteria for essential nutrients should be guaranteed. These interactions are lacking in isolated laboratory cultures. Further, the marine shear stress, hypersalinity, and antagonists, which induce unique metabolite elaborations, are missing in laboratory cultures. That notwithstanding, these efforts may lead to valuable results. In fact, marine bacteria are significant reservoirs of a plethora of bioactive molecules which have never been found in terrestrial organisms. Moreover, microalgae represent an important, still underestimated source of bioactive metabolites, such as antiviral and anti-AIDS agents. Seaweeds as well produce many different, interesting biologically active substances, such as sulphated polysaccharides, which are promising compounds for drug development [<xref rid="B171-marinedrugs-17-00464" ref-type="bibr">171</xref>]. For example, carbohydrate recognition molecules, such as lectins from green seaweeds, have the potential to be used as antitumor and antiviral agents, but they have been rarely investigated [<xref rid="B172-marinedrugs-17-00464" ref-type="bibr">172</xref>]. Notably, a natural compound can have variable effects on the human body, as host factors are different. The promising results obtained by an in vitro experiment may not show the same effects in a patient&#x02019;s body. Moreover, the human body under an inflammatory process presents an activated immune system that can consider even a therapeutic compound a threat. Thus, proper safety assessments of the studied metabolites are required. The optimal dosage determination is very important, as this parameter distinguishes whether a compound will act as a drug or a poison. From a technological point of view, novel cost-effective and large-scale fermentation strategies ought to be devised, and particular attention should be paid to the conditions under which the secondary metabolites are produced. Recreating the physical, chemical, and biological conditions of a marine environment is hardly an achievable task. Metabolic and protein engineering can improve the efficacy of some of the marine candidates with pharmaceutical potential. In the future, the efforts and advances in this direction will certainly open the way for extraordinary discoveries for novel applications of marine-derived compounds in biotechnology and biomedicine.</p></sec></body><back><ack><title>Acknowledgments</title><p>Authors gratefully acknowledge the excellence department project of the Italian Ministry of Education, University and Research (MIUR) &#x0201c;Excellence for Aquatic Animal Health&#x02014;ECCE AQUA&#x0201d;.</p></ack><notes><title>Author Contributions</title><p>Conceptualization, writing and original draft preparation, N.B.; software, H.B.P.; editing, S.T.J.; review, revision and funding acquisition, F.V.</p></notes><notes><title>Funding</title><p>This research was funded by Veneto Region project &#x0201c;Safe, Smart, Sustainable Food for Health (3S_4H)&#x0201d;&#x02014;POR FESR 2014-2020, 1.1.4. DGR n. 1139.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></notes><ref-list><title>References</title><ref id="B1-marinedrugs-17-00464"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jahromi</surname><given-names>S.T.</given-names></name><name><surname>Barzkar</surname><given-names>N.</given-names></name></person-group><article-title>Marine bacterial chitinase as sources of energy, eco-friendly agent, and industrial biocatalyst</article-title><source>Int. J. Biol. Macromol.</source><year>2018</year><volume>120</volume><fpage>2147</fpage><lpage>2154</lpage><pub-id pub-id-type="doi">10.1016/j.ijbiomac.2018.09.083</pub-id><?supplied-pmid 30223053?><pub-id pub-id-type="pmid">30223053</pub-id></element-citation></ref><ref id="B2-marinedrugs-17-00464"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rey-Ladino</surname><given-names>J.</given-names></name><name><surname>Ross</surname><given-names>A.G.</given-names></name><name><surname>Cripps</surname><given-names>A.W.</given-names></name><name><surname>McManus</surname><given-names>D.P.</given-names></name><name><surname>Quinn</surname><given-names>R.</given-names></name></person-group><article-title>Natural products and the search for novel vaccine adjuvants</article-title><source>Vaccine</source><year>2011</year><volume>29</volume><fpage>6464</fpage><lpage>6471</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2011.07.041</pub-id><?supplied-pmid 21787827?><pub-id pub-id-type="pmid">21787827</pub-id></element-citation></ref><ref id="B3-marinedrugs-17-00464"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Donia</surname><given-names>M.</given-names></name><name><surname>Hamann</surname><given-names>M.T.</given-names></name></person-group><article-title>Marine natural products and their potential applications as anti-infective agents</article-title><source>Lancet Infect. Dis.</source><year>2003</year><volume>3</volume><fpage>338</fpage><lpage>348</lpage><pub-id pub-id-type="doi">10.1016/S1473-3099(03)00655-8</pub-id><pub-id pub-id-type="pmid">12781505</pub-id></element-citation></ref><ref id="B4-marinedrugs-17-00464"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Proksch</surname><given-names>P.</given-names></name><name><surname>Edrada</surname><given-names>R.</given-names></name><name><surname>Ebel</surname><given-names>R.</given-names></name></person-group><article-title>Drugs from the seas-current status and microbiological implications</article-title><source>Appl. Microbiol. Biotechnol.</source><year>2002</year><volume>59</volume><fpage>125</fpage><lpage>134</lpage><pub-id pub-id-type="pmid">12111137</pub-id></element-citation></ref><ref id="B5-marinedrugs-17-00464"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blunt</surname><given-names>J.W.</given-names></name><name><surname>Copp</surname><given-names>B.R.</given-names></name><name><surname>Hu</surname><given-names>W.-P.</given-names></name><name><surname>Munro</surname><given-names>M.H.</given-names></name><name><surname>Northcote</surname><given-names>P.T.</given-names></name><name><surname>Prinsep</surname><given-names>M.R.</given-names></name></person-group><article-title>Marine natural products</article-title><source>Nat. Prod. Rep.</source><year>2009</year><volume>26</volume><fpage>170</fpage><pub-id pub-id-type="doi">10.1039/b805113p</pub-id><?supplied-pmid 19177222?><pub-id pub-id-type="pmid">19177222</pub-id></element-citation></ref><ref id="B6-marinedrugs-17-00464"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jahromi</surname><given-names>S.T.</given-names></name><name><surname>Barzkar</surname><given-names>N.</given-names></name></person-group><article-title>Future direction in marine bacterial agarases for industrial applications</article-title><source>Appl. Microbiol. Biotechnol.</source><year>2018</year><volume>102</volume><fpage>6847</fpage><lpage>6863</lpage><pub-id pub-id-type="doi">10.1007/s00253-018-9156-5</pub-id><?supplied-pmid 29909571?><pub-id pub-id-type="pmid">29909571</pub-id></element-citation></ref><ref id="B7-marinedrugs-17-00464"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McArthur</surname><given-names>K.A.</given-names></name><name><surname>Mitchell</surname><given-names>S.S.</given-names></name><name><surname>Tsueng</surname><given-names>G.</given-names></name><name><surname>Rheingold</surname><given-names>A.</given-names></name><name><surname>White</surname><given-names>D.J.</given-names></name><name><surname>Grodberg</surname><given-names>J.</given-names></name><name><surname>Lam</surname><given-names>K.S.</given-names></name><name><surname>Potts</surname><given-names>B.C.</given-names></name></person-group><article-title>Lynamicins a&#x02212;e, chlorinated bisindole pyrrole antibiotics from a novel marine actinomycete</article-title><source>J. Nat. Prod.</source><year>2008</year><volume>71</volume><fpage>1732</fpage><lpage>1737</lpage><pub-id pub-id-type="doi">10.1021/np800286d</pub-id><?supplied-pmid 18842058?><pub-id pub-id-type="pmid">18842058</pub-id></element-citation></ref><ref id="B8-marinedrugs-17-00464"><label>8.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Baker</surname><given-names>J.T.</given-names></name></person-group><article-title>Seaweeds in pharmaceutical studies and applications</article-title><source>XIth International Seaweed Symposium</source><person-group person-group-type="editor"><name><surname>Bird</surname><given-names>C.J.</given-names></name><name><surname>Ragan</surname><given-names>M.A.</given-names></name></person-group><publisher-name>Kluwer Academic Publishers Group</publisher-name><publisher-loc>Qingdao, China</publisher-loc><year>1984</year><volume>116/117</volume><fpage>29</fpage><lpage>40</lpage></element-citation></ref><ref id="B9-marinedrugs-17-00464"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El-Gendy</surname><given-names>M.M.</given-names></name><name><surname>Hawas</surname><given-names>U.W.</given-names></name><name><surname>Jaspars</surname><given-names>M.</given-names></name></person-group><article-title>Novel bioactive metabolites from a marine derived bacterium nocardia sp. Alaa 2000</article-title><source>J. Antibiot.</source><year>2008</year><volume>61</volume><fpage>379</fpage><pub-id pub-id-type="doi">10.1038/ja.2008.53</pub-id><?supplied-pmid 18667786?><pub-id pub-id-type="pmid">18667786</pub-id></element-citation></ref><ref id="B10-marinedrugs-17-00464"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gil-Turnes</surname><given-names>M.S.</given-names></name><name><surname>Hay</surname><given-names>M.E.</given-names></name><name><surname>Fenical</surname><given-names>W.</given-names></name></person-group><article-title>Symbiotic marine bacteria chemically defend crustacean embryos from a pathogenic fungus</article-title><source>Science</source><year>1989</year><volume>246</volume><fpage>116</fpage><pub-id pub-id-type="doi">10.1126/science.2781297</pub-id><pub-id pub-id-type="pmid">2781297</pub-id></element-citation></ref><ref id="B11-marinedrugs-17-00464"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deshmukh</surname><given-names>S.K.</given-names></name><name><surname>Prakash</surname><given-names>V.</given-names></name><name><surname>Ranjan</surname><given-names>N.</given-names></name></person-group><article-title>Marine fungi: A source of potential anticancer compounds</article-title><source>Front. Microbiol.</source><year>2018</year><volume>8</volume><fpage>2536</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2017.02536</pub-id><pub-id pub-id-type="pmid">29354097</pub-id></element-citation></ref><ref id="B12-marinedrugs-17-00464"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname><given-names>H.P.</given-names></name><name><surname>Zhang</surname><given-names>D.</given-names></name><name><surname>Lee</surname><given-names>U.</given-names></name><name><surname>Kang</surname><given-names>J.S.</given-names></name><name><surname>Choi</surname><given-names>H.D.</given-names></name><name><surname>Son</surname><given-names>B.W.</given-names></name></person-group><article-title>Dehydroxychlorofusarielin b, an antibacterial polyoxygenated decalin derivative from the marine-derived fungus aspergillus sp.</article-title><source>J. Nat. Prod.</source><year>2007</year><volume>70</volume><fpage>1188</fpage><lpage>1190</lpage><pub-id pub-id-type="doi">10.1021/np060552g</pub-id><?supplied-pmid 17564467?><pub-id pub-id-type="pmid">17564467</pub-id></element-citation></ref><ref id="B13-marinedrugs-17-00464"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trisuwan</surname><given-names>K.</given-names></name><name><surname>Rukachaisirikul</surname><given-names>V.</given-names></name><name><surname>Sukpondma</surname><given-names>Y.</given-names></name><name><surname>Preedanon</surname><given-names>S.</given-names></name><name><surname>Phongpaichit</surname><given-names>S.</given-names></name><name><surname>Rungjindamai</surname><given-names>N.</given-names></name><name><surname>Sakayaroj</surname><given-names>J.</given-names></name></person-group><article-title>Epoxydons and a pyrone from the marine-derived fungus nigrospora sp. Psu-f5</article-title><source>J. Nat. Prod.</source><year>2008</year><volume>71</volume><fpage>1323</fpage><lpage>1326</lpage><pub-id pub-id-type="doi">10.1021/np8002595</pub-id><?supplied-pmid 18646829?><pub-id pub-id-type="pmid">18646829</pub-id></element-citation></ref><ref id="B14-marinedrugs-17-00464"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Newman</surname><given-names>D.J.</given-names></name><name><surname>Cragg</surname><given-names>G.M.</given-names></name></person-group><article-title>Marine natural products and related compounds in clinical and advanced preclinical trials</article-title><source>J. Nat. Prod.</source><year>2004</year><volume>67</volume><fpage>1216</fpage><lpage>1238</lpage><pub-id pub-id-type="doi">10.1021/np040031y</pub-id><?supplied-pmid 15332835?><pub-id pub-id-type="pmid">15332835</pub-id></element-citation></ref><ref id="B15-marinedrugs-17-00464"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prachyawarakorn</surname><given-names>V.</given-names></name><name><surname>Mahidol</surname><given-names>C.</given-names></name><name><surname>Sureram</surname><given-names>S.</given-names></name><name><surname>Sangpetsiripan</surname><given-names>S.</given-names></name><name><surname>Wiyakrutta</surname><given-names>S.</given-names></name><name><surname>Ruchirawat</surname><given-names>S.</given-names></name><name><surname>Kittakoop</surname><given-names>P.</given-names></name></person-group><article-title>Diketopiperazines and phthalides from a marine derived fungus of the order pleosporales</article-title><source>Planta Med.</source><year>2008</year><volume>74</volume><fpage>69</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.1055/s-2007-993783</pub-id><?supplied-pmid 18203053?><pub-id pub-id-type="pmid">18203053</pub-id></element-citation></ref><ref id="B16-marinedrugs-17-00464"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>J.</given-names></name><name><surname>Kjer</surname><given-names>J.</given-names></name><name><surname>Sendker</surname><given-names>J.</given-names></name><name><surname>Wray</surname><given-names>V.</given-names></name><name><surname>Guan</surname><given-names>H.</given-names></name><name><surname>Edrada</surname><given-names>R.</given-names></name><name><surname>Lin</surname><given-names>W.</given-names></name><name><surname>Wu</surname><given-names>J.</given-names></name><name><surname>Proksch</surname><given-names>P.</given-names></name></person-group><article-title>Chromones from the endophytic fungus <italic>pestalotiopsis</italic> sp. Isolated from the chinese mangrove plant rhizophora mucronata</article-title><source>J. Nat. Prod.</source><year>2009</year><volume>72</volume><fpage>662</fpage><lpage>665</lpage><pub-id pub-id-type="doi">10.1021/np800748u</pub-id><?supplied-pmid 19271764?><pub-id pub-id-type="pmid">19271764</pub-id></element-citation></ref><ref id="B17-marinedrugs-17-00464"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pal</surname><given-names>A.</given-names></name><name><surname>Kamthania</surname><given-names>M.C.</given-names></name><name><surname>Kumar</surname><given-names>A.</given-names></name></person-group><article-title>Bioactive compounds and properties of seaweeds&#x02014;A review</article-title><source>Open Access Libr. J.</source><year>2014</year><volume>1</volume><fpage>1</fpage><pub-id pub-id-type="doi">10.4236/oalib.1100752</pub-id></element-citation></ref><ref id="B18-marinedrugs-17-00464"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Debbab</surname><given-names>A.</given-names></name><name><surname>Aly</surname><given-names>A.H.</given-names></name><name><surname>Lin</surname><given-names>W.H.</given-names></name><name><surname>Proksch</surname><given-names>P.</given-names></name></person-group><article-title>Bioactive compounds from marine bacteria and fungi</article-title><source>Microb. Biotechnol.</source><year>2010</year><volume>3</volume><fpage>544</fpage><lpage>563</lpage><pub-id pub-id-type="doi">10.1111/j.1751-7915.2010.00179.x</pub-id><?supplied-pmid 21255352?><pub-id pub-id-type="pmid">21255352</pub-id></element-citation></ref><ref id="B19-marinedrugs-17-00464"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>D.-S.</given-names></name><name><surname>Jang</surname><given-names>J.-H.</given-names></name><name><surname>Ko</surname><given-names>W.</given-names></name><name><surname>Kim</surname><given-names>K.-S.</given-names></name><name><surname>Sohn</surname><given-names>J.H.</given-names></name><name><surname>Kang</surname><given-names>M.-S.</given-names></name><name><surname>Ahn</surname><given-names>J.S.</given-names></name><name><surname>Kim</surname><given-names>Y.-C.</given-names></name><name><surname>Oh</surname><given-names>H.</given-names></name></person-group><article-title>Ptp1b inhibitory and anti-inflammatory effects of secondary metabolites isolated from the marine-derived fungus penicillium sp. Jf-55</article-title><source>Mar. Drugs</source><year>2013</year><volume>11</volume><fpage>1409</fpage><lpage>1426</lpage><pub-id pub-id-type="doi">10.3390/md11041409</pub-id><?supplied-pmid 23612372?><pub-id pub-id-type="pmid">23612372</pub-id></element-citation></ref><ref id="B20-marinedrugs-17-00464"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lam</surname><given-names>K.S.</given-names></name><name><surname>Tsueng</surname><given-names>G.</given-names></name><name><surname>McArthur</surname><given-names>K.A.</given-names></name><name><surname>Mitchell</surname><given-names>S.S.</given-names></name><name><surname>Potts</surname><given-names>B.C.</given-names></name><name><surname>Xu</surname><given-names>J.</given-names></name></person-group><article-title>Effects of halogens on the production of salinosporamides by the obligate marine actinomycete salinispora tropica</article-title><source>J. Antibiot.</source><year>2007</year><volume>60</volume><fpage>13</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.1038/ja.2007.2</pub-id><?supplied-pmid 17390584?><pub-id pub-id-type="pmid">17390584</pub-id></element-citation></ref><ref id="B21-marinedrugs-17-00464"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nicholson</surname><given-names>B.</given-names></name><name><surname>Lloyd</surname><given-names>G.K.</given-names></name><name><surname>Miller</surname><given-names>B.R.</given-names></name><name><surname>Palladino</surname><given-names>M.A.</given-names></name><name><surname>Kiso</surname><given-names>Y.</given-names></name><name><surname>Hayashi</surname><given-names>Y.</given-names></name><name><surname>Neuteboom</surname><given-names>S.T.</given-names></name></person-group><article-title>Npi-2358 is a tubulin-depolymerizing agent: In-vitro evidence for activity as a tumor vascular-disrupting agent</article-title><source>Anti-Cancer Drugs</source><year>2006</year><volume>17</volume><fpage>25</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1097/01.cad.0000182745.01612.8a</pub-id><pub-id pub-id-type="pmid">16317287</pub-id></element-citation></ref><ref id="B22-marinedrugs-17-00464"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>M.-Y.</given-names></name><name><surname>Sohn</surname><given-names>J.H.</given-names></name><name><surname>Ahn</surname><given-names>J.S.</given-names></name><name><surname>Oh</surname><given-names>H.</given-names></name></person-group><article-title>Alternaramide, a cyclic depsipeptide from the marine-derived fungus alternaria sp. Sf-5016</article-title><source>J. Nat. Prod.</source><year>2009</year><volume>72</volume><fpage>2065</fpage><lpage>2068</lpage><pub-id pub-id-type="doi">10.1021/np900464p</pub-id><?supplied-pmid 19943624?><pub-id pub-id-type="pmid">19943624</pub-id></element-citation></ref><ref id="B23-marinedrugs-17-00464"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>X.</given-names></name><name><surname>Xu</surname><given-names>Q.Z.</given-names></name><name><surname>Shen</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Jiao</surname><given-names>B.</given-names></name><name><surname>Zhang</surname><given-names>W.</given-names></name><name><surname>Ni</surname><given-names>K.</given-names></name></person-group><article-title>Macrolactin s, a novel macrolactin antibiotic from marine bacillus sp.</article-title><source>Nat. Prod. Res.</source><year>2008</year><volume>22</volume><fpage>342</fpage><lpage>347</lpage><pub-id pub-id-type="doi">10.1080/14786410701768162</pub-id><?supplied-pmid 18322849?><pub-id pub-id-type="pmid">18322849</pub-id></element-citation></ref><ref id="B24-marinedrugs-17-00464"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koizumi</surname><given-names>Y.</given-names></name><name><surname>Arai</surname><given-names>M.</given-names></name><name><surname>Tomoda</surname><given-names>H.</given-names></name><name><surname>Omura</surname><given-names>S.</given-names></name></person-group><article-title>Fungerin, a fungal alkaloid, arrests the cell cycle in m phase by inhibition of microtubule polymerization</article-title><source>J. antIbiot.</source><year>2004</year><volume>57</volume><fpage>415</fpage><lpage>420</lpage><pub-id pub-id-type="doi">10.7164/antibiotics.57.415</pub-id><?supplied-pmid 15376553?><pub-id pub-id-type="pmid">15376553</pub-id></element-citation></ref><ref id="B25-marinedrugs-17-00464"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwan</surname><given-names>J.C.</given-names></name><name><surname>Eksioglu</surname><given-names>E.A.</given-names></name><name><surname>Liu</surname><given-names>C.</given-names></name><name><surname>Paul</surname><given-names>V.J.</given-names></name><name><surname>Luesch</surname><given-names>H.</given-names></name></person-group><article-title>Grassystatins a&#x02212;c from marine cyanobacteria, potent cathepsin e inhibitors that reduce antigen presentation</article-title><source>J. Med. Chem.</source><year>2009</year><volume>52</volume><fpage>5732</fpage><lpage>5747</lpage><pub-id pub-id-type="doi">10.1021/jm9009394</pub-id><?supplied-pmid 19715320?><pub-id pub-id-type="pmid">19715320</pub-id></element-citation></ref><ref id="B26-marinedrugs-17-00464"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taniguchi</surname><given-names>M.</given-names></name><name><surname>Nunnery</surname><given-names>J.K.</given-names></name><name><surname>Engene</surname><given-names>N.</given-names></name><name><surname>Esquenazi</surname><given-names>E.</given-names></name><name><surname>Byrum</surname><given-names>T.</given-names></name><name><surname>Dorrestein</surname><given-names>P.C.</given-names></name><name><surname>Gerwick</surname><given-names>W.H.</given-names></name></person-group><article-title>Palmyramide a, a cyclic depsipeptide from a palmyra atoll collection of the marine cyanobacterium lyngbya majuscula</article-title><source>J. Nat. Prod.</source><year>2009</year><volume>73</volume><fpage>393</fpage><lpage>398</lpage><pub-id pub-id-type="doi">10.1021/np900428h</pub-id></element-citation></ref><ref id="B27-marinedrugs-17-00464"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Medina</surname><given-names>R.A.</given-names></name><name><surname>Goeger</surname><given-names>D.E.</given-names></name><name><surname>Hills</surname><given-names>P.</given-names></name><name><surname>Mooberry</surname><given-names>S.L.</given-names></name><name><surname>Huang</surname><given-names>N.</given-names></name><name><surname>Romero</surname><given-names>L.I.</given-names></name><name><surname>Ortega-Barr&#x000ed;a</surname><given-names>E.</given-names></name><name><surname>Gerwick</surname><given-names>W.H.</given-names></name><name><surname>McPhail</surname><given-names>K.L.</given-names></name></person-group><article-title>Coibamide a, a potent antiproliferative cyclic depsipeptide from the panamanian marine cyanobacterium leptolyngbya sp.</article-title><source>J. Am. Chem. Soc.</source><year>2008</year><volume>130</volume><fpage>6324</fpage><lpage>6325</lpage><pub-id pub-id-type="doi">10.1021/ja801383f</pub-id><?supplied-pmid 18444611?><pub-id pub-id-type="pmid">18444611</pub-id></element-citation></ref><ref id="B28-marinedrugs-17-00464"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yao</surname><given-names>G.</given-names></name><name><surname>Pan</surname><given-names>Z.</given-names></name><name><surname>Wu</surname><given-names>C.</given-names></name><name><surname>Wang</surname><given-names>W.</given-names></name><name><surname>Fang</surname><given-names>L.</given-names></name><name><surname>Su</surname><given-names>W.</given-names></name></person-group><article-title>Efficient synthesis and stereochemical revision of coibamide a</article-title><source>J. Am. Chem. Soc.</source><year>2015</year><volume>137</volume><fpage>13488</fpage><lpage>13491</lpage><pub-id pub-id-type="doi">10.1021/jacs.5b09286</pub-id><?supplied-pmid 26469305?><pub-id pub-id-type="pmid">26469305</pub-id></element-citation></ref><ref id="B29-marinedrugs-17-00464"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramaswamy</surname><given-names>A.V.</given-names></name><name><surname>Sorrels</surname><given-names>C.M.</given-names></name><name><surname>Gerwick</surname><given-names>W.H.</given-names></name></person-group><article-title>Cloning and biochemical characterization of the hectochlorin biosynthetic gene cluster from the marine cyanobacterium lyngbya majuscula</article-title><source>J. Nat. Prod.</source><year>2007</year><volume>70</volume><fpage>1977</fpage><lpage>1986</lpage><pub-id pub-id-type="doi">10.1021/np0704250</pub-id><?supplied-pmid 18001088?><pub-id pub-id-type="pmid">18001088</pub-id></element-citation></ref><ref id="B30-marinedrugs-17-00464"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matthew</surname><given-names>S.</given-names></name><name><surname>Ross</surname><given-names>C.</given-names></name><name><surname>Paul</surname><given-names>V.J.</given-names></name><name><surname>Luesch</surname><given-names>H.</given-names></name></person-group><article-title>Pompanopeptins a and b, new cyclic peptides from the marine cyanobacterium lyngbya confervoides</article-title><source>Tetrahedron</source><year>2008</year><volume>64</volume><fpage>4081</fpage><lpage>4089</lpage><pub-id pub-id-type="doi">10.1016/j.tet.2008.02.035</pub-id></element-citation></ref><ref id="B31-marinedrugs-17-00464"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Plaza</surname><given-names>M.</given-names></name><name><surname>Cifuentes</surname><given-names>A.</given-names></name><name><surname>Ib&#x000e1;&#x000f1;ez</surname><given-names>E.</given-names></name></person-group><article-title>In the search of new functional food ingredients from algae</article-title><source>Trends Food Sci. Technol.</source><year>2008</year><volume>19</volume><fpage>31</fpage><lpage>39</lpage><pub-id pub-id-type="doi">10.1016/j.tifs.2007.07.012</pub-id></element-citation></ref><ref id="B32-marinedrugs-17-00464"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Imhoff</surname><given-names>J.F.</given-names></name><name><surname>Labes</surname><given-names>A.</given-names></name><name><surname>Wiese</surname><given-names>J.</given-names></name></person-group><article-title>Bio-mining the microbial treasures of the ocean: New natural products</article-title><source>Biotechnol. Adv.</source><year>2011</year><volume>29</volume><fpage>468</fpage><lpage>482</lpage><pub-id pub-id-type="doi">10.1016/j.biotechadv.2011.03.001</pub-id><?supplied-pmid 21419836?><pub-id pub-id-type="pmid">21419836</pub-id></element-citation></ref><ref id="B33-marinedrugs-17-00464"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Plaza</surname><given-names>M.</given-names></name><name><surname>Herrero</surname><given-names>M.</given-names></name><name><surname>Cifuentes</surname><given-names>A.</given-names></name><name><surname>Ib&#x000e1;&#x000f1;ez</surname><given-names>E.</given-names></name></person-group><article-title>Innovative natural functional ingredients from microalgae</article-title><source>J. Agric. Food Chem.</source><year>2009</year><volume>57</volume><fpage>7159</fpage><lpage>7170</lpage><pub-id pub-id-type="doi">10.1021/jf901070g</pub-id><?supplied-pmid 19650628?><pub-id pub-id-type="pmid">19650628</pub-id></element-citation></ref><ref id="B34-marinedrugs-17-00464"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mimouni</surname><given-names>V.</given-names></name><name><surname>Ulmann</surname><given-names>L.</given-names></name><name><surname>Pasquet</surname><given-names>V.</given-names></name><name><surname>Mathieu</surname><given-names>M.</given-names></name><name><surname>Picot</surname><given-names>L.</given-names></name><name><surname>Bougaran</surname><given-names>G.</given-names></name><name><surname>Cadoret</surname><given-names>J.-P.</given-names></name><name><surname>Morant-Manceau</surname><given-names>A.</given-names></name><name><surname>Schoefs</surname><given-names>B.</given-names></name></person-group><article-title>The potential of microalgae for the production of bioactive molecules of pharmaceutical interest</article-title><source>Curr. Pharmac. Biotechnol.</source><year>2012</year><volume>13</volume><fpage>2733</fpage><lpage>2750</lpage><pub-id pub-id-type="doi">10.2174/138920112804724828</pub-id></element-citation></ref><ref id="B35-marinedrugs-17-00464"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>S.-K.</given-names></name><name><surname>Karadeniz</surname><given-names>F.</given-names></name></person-group><article-title>Anti-hiv activity of extracts and compounds from marine algae</article-title><source>Adv. Food Nutr. Res.</source><year>2011</year><volume>64</volume><fpage>255</fpage><lpage>265</lpage><?supplied-pmid 22054953?><pub-id pub-id-type="pmid">22054953</pub-id></element-citation></ref><ref id="B36-marinedrugs-17-00464"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yim</surname><given-names>J.H.</given-names></name><name><surname>Kim</surname><given-names>S.J.</given-names></name><name><surname>Ahn</surname><given-names>S.H.</given-names></name><name><surname>Lee</surname><given-names>C.K.</given-names></name><name><surname>Rhie</surname><given-names>K.T.</given-names></name><name><surname>Lee</surname><given-names>H.K.</given-names></name></person-group><article-title>Antiviral effects of sulfated exopolysaccharide from the marine microalga gyrodinium impudicum strain kg03</article-title><source>Mar. Biotechnol.</source><year>2004</year><volume>6</volume><fpage>17</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1007/s10126-003-0002-z</pub-id><?supplied-pmid 14508657?><pub-id pub-id-type="pmid">14508657</pub-id></element-citation></ref><ref id="B37-marinedrugs-17-00464"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nuhu</surname><given-names>A.A.</given-names></name></person-group><article-title>Spirulina (arthrospira): An important source of nutritional and medicinal compounds</article-title><source>J. Mar. Biol.</source><year>2013</year><volume>2013</volume><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1155/2013/325636</pub-id></element-citation></ref><ref id="B38-marinedrugs-17-00464"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>Y.</given-names></name><name><surname>He</surname><given-names>H.</given-names></name><name><surname>Schulz</surname><given-names>S.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Fusetani</surname><given-names>N.</given-names></name><name><surname>Xiong</surname><given-names>H.</given-names></name><name><surname>Xiao</surname><given-names>X.</given-names></name><name><surname>Qian</surname><given-names>P.-Y.</given-names></name></person-group><article-title>Potent antifouling compounds produced by marine streptomyces</article-title><source>Bioresour. Technol.</source><year>2010</year><volume>101</volume><fpage>1331</fpage><lpage>1336</lpage><pub-id pub-id-type="doi">10.1016/j.biortech.2009.09.046</pub-id><?supplied-pmid 19818601?><pub-id pub-id-type="pmid">19818601</pub-id></element-citation></ref><ref id="B39-marinedrugs-17-00464"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>L.T.</given-names></name><name><surname>Goh</surname><given-names>B.P.L.</given-names></name><name><surname>Tripathi</surname><given-names>A.</given-names></name><name><surname>Lim</surname><given-names>M.G.</given-names></name><name><surname>Dickinson</surname><given-names>G.H.</given-names></name><name><surname>Lee</surname><given-names>S.S.C.</given-names></name><name><surname>Teo</surname><given-names>S.L.M.</given-names></name></person-group><article-title>Natural antifoulants from the marine cyanobacterium lyngbya majuscula</article-title><source>Biofouling</source><year>2010</year><volume>26</volume><fpage>685</fpage><lpage>695</lpage><pub-id pub-id-type="doi">10.1080/08927014.2010.508343</pub-id><pub-id pub-id-type="pmid">20658384</pub-id></element-citation></ref><ref id="B40-marinedrugs-17-00464"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sivonen</surname><given-names>K.</given-names></name><name><surname>Leikoski</surname><given-names>N.</given-names></name><name><surname>Fewer</surname><given-names>D.P.</given-names></name><name><surname>Jokela</surname><given-names>J.</given-names></name></person-group><article-title>Cyanobactins&#x02014;Ribosomal cyclic peptides produced by cyanobacteria</article-title><source>Appl. Microbiol. Biotechnol.</source><year>2010</year><volume>86</volume><fpage>1213</fpage><lpage>1225</lpage><pub-id pub-id-type="doi">10.1007/s00253-010-2482-x</pub-id><pub-id pub-id-type="pmid">20195859</pub-id></element-citation></ref><ref id="B41-marinedrugs-17-00464"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taori</surname><given-names>K.</given-names></name><name><surname>Matthew</surname><given-names>S.</given-names></name><name><surname>Rocca</surname><given-names>J.R.</given-names></name><name><surname>Paul</surname><given-names>V.J.</given-names></name><name><surname>Luesch</surname><given-names>H.</given-names></name></person-group><article-title>Lyngbyastatins 5&#x02013;7, potent elastase inhibitors from floridian marine cyanobacteria, lyngbya spp.</article-title><source>J. Nat. Prod.</source><year>2007</year><volume>70</volume><fpage>1593</fpage><lpage>1600</lpage><pub-id pub-id-type="doi">10.1021/np0702436</pub-id><pub-id pub-id-type="pmid">17910513</pub-id></element-citation></ref><ref id="B42-marinedrugs-17-00464"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Volk</surname><given-names>R.-B.</given-names></name><name><surname>Furkert</surname><given-names>F.H.</given-names></name></person-group><article-title>Antialgal, antibacterial and antifungal activity of two metabolites produced and excreted by cyanobacteria during growth</article-title><source>Microbiol. Res.</source><year>2006</year><volume>161</volume><fpage>180</fpage><lpage>186</lpage><pub-id pub-id-type="doi">10.1016/j.micres.2005.08.005</pub-id><?supplied-pmid 16427523?><pub-id pub-id-type="pmid">16427523</pub-id></element-citation></ref><ref id="B43-marinedrugs-17-00464"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tiwari</surname><given-names>A.</given-names></name><name><surname>Sharma</surname><given-names>D.</given-names></name></person-group><article-title>Antibacterial activity of bloom forming cyanobacteria against clinically isolated human pathogenic microbes</article-title><source>J. Algal Biomass Utilization</source><year>2013</year><volume>4</volume><fpage>83</fpage><lpage>89</lpage></element-citation></ref><ref id="B44-marinedrugs-17-00464"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martins</surname><given-names>R.F.</given-names></name><name><surname>Ramos</surname><given-names>M.F.</given-names></name><name><surname>Herfindal</surname><given-names>L.</given-names></name><name><surname>Sousa</surname><given-names>J.A.</given-names></name><name><surname>Sk&#x000e6;rven</surname><given-names>K.</given-names></name><name><surname>Vasconcelos</surname><given-names>V.M.</given-names></name></person-group><article-title>Antimicrobial and cytotoxic assessment of marine cyanobacteria-synechocystis and synechococcus</article-title><source>Mar. Drugs</source><year>2008</year><volume>6</volume><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.3390/md6010001</pub-id><?supplied-pmid 18648669?><pub-id pub-id-type="pmid">18648669</pub-id></element-citation></ref><ref id="B45-marinedrugs-17-00464"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jaki</surname><given-names>B.</given-names></name><name><surname>Orjala</surname><given-names>J.</given-names></name><name><surname>Sticher</surname><given-names>O.</given-names></name></person-group><article-title>A novel extracellular diterpenoid with antibacterial activity from the cyanobacterium nostoc commune</article-title><source>J. Nat. Prod.</source><year>1999</year><volume>62</volume><fpage>502</fpage><lpage>503</lpage><pub-id pub-id-type="doi">10.1021/np980444x</pub-id><?supplied-pmid 10096870?><pub-id pub-id-type="pmid">10096870</pub-id></element-citation></ref><ref id="B46-marinedrugs-17-00464"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gekwick</surname><given-names>W.H.</given-names></name><name><surname>Reyes</surname><given-names>S.</given-names></name><name><surname>Alvarado</surname><given-names>B.</given-names></name></person-group><article-title>Two malyngamides from the caribbean cyanobacterium lyngbya majuscula</article-title><source>Phytochemistry</source><year>1987</year><volume>26</volume><fpage>1701</fpage><lpage>1704</lpage><pub-id pub-id-type="doi">10.1016/S0031-9422(00)82271-2</pub-id></element-citation></ref><ref id="B47-marinedrugs-17-00464"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raveh</surname><given-names>A.</given-names></name><name><surname>Carmeli</surname><given-names>S.</given-names></name></person-group><article-title>Antimicrobial ambiguines from the cyanobacterium fischerella sp. Collected in israel</article-title><source>J. Nat. Prod.</source><year>2007</year><volume>70</volume><fpage>196</fpage><lpage>201</lpage><pub-id pub-id-type="doi">10.1021/np060495r</pub-id><pub-id pub-id-type="pmid">17315959</pub-id></element-citation></ref><ref id="B48-marinedrugs-17-00464"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ishida</surname><given-names>K.</given-names></name><name><surname>Murakami</surname><given-names>M.</given-names></name></person-group><article-title>Kasumigamide, an antialgal peptide from the cyanobacterium microcystis aeruginosa</article-title><source>J. Org. Chem.</source><year>2000</year><volume>65</volume><fpage>5898</fpage><lpage>5900</lpage><pub-id pub-id-type="doi">10.1021/jo991918f</pub-id><pub-id pub-id-type="pmid">10987919</pub-id></element-citation></ref><ref id="B49-marinedrugs-17-00464"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luesch</surname><given-names>H.</given-names></name><name><surname>Harrigan</surname><given-names>G.</given-names></name><name><surname>Goetz</surname><given-names>G.</given-names></name><name><surname>Horgen</surname><given-names>F.</given-names></name></person-group><article-title>The cyanobacterial origin of potent anticancer agents originally isolated from sea hares</article-title><source>Curr. Med. Chem.</source><year>2002</year><volume>9</volume><fpage>1791</fpage><lpage>1806</lpage><pub-id pub-id-type="doi">10.2174/0929867023369051</pub-id><pub-id pub-id-type="pmid">12369878</pub-id></element-citation></ref><ref id="B50-marinedrugs-17-00464"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mi</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>He</surname><given-names>S.</given-names></name><name><surname>Yan</surname><given-names>X.</given-names></name></person-group><article-title>New peptides isolated from marine cyanobacteria, an overview over the past decade</article-title><source>Mar. Drugs</source><year>2017</year><volume>15</volume><elocation-id>132</elocation-id><pub-id pub-id-type="doi">10.3390/md15050132</pub-id></element-citation></ref><ref id="B51-marinedrugs-17-00464"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vijayakumar</surname><given-names>S.</given-names></name><name><surname>Menakha</surname><given-names>M.</given-names></name></person-group><article-title>Pharmaceutical applications of cyanobacteria&#x02014;A review</article-title><source>J. Acute Med.</source><year>2015</year><volume>5</volume><fpage>15</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.1016/j.jacme.2015.02.004</pub-id></element-citation></ref><ref id="B52-marinedrugs-17-00464"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trimurtulu</surname><given-names>G.</given-names></name><name><surname>Ohtani</surname><given-names>I.</given-names></name><name><surname>Patterson</surname><given-names>G.M.</given-names></name><name><surname>Moore</surname><given-names>R.E.</given-names></name><name><surname>Corbett</surname><given-names>T.H.</given-names></name><name><surname>Valeriote</surname><given-names>F.A.</given-names></name><name><surname>Demchik</surname><given-names>L.</given-names></name></person-group><article-title>Total structures of cryptophycins, potent antitumor depsipeptides from the blue-green alga nostoc sp. Strain gsv 224</article-title><source>J. Am. Chem. Soc.</source><year>1994</year><volume>116</volume><fpage>4729</fpage><lpage>4737</lpage><pub-id pub-id-type="doi">10.1021/ja00090a020</pub-id></element-citation></ref><ref id="B53-marinedrugs-17-00464"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Panda</surname><given-names>D.</given-names></name><name><surname>DeLuca</surname><given-names>K.</given-names></name><name><surname>Williams</surname><given-names>D.</given-names></name><name><surname>Jordan</surname><given-names>M.A.</given-names></name><name><surname>Wilson</surname><given-names>L.</given-names></name></person-group><article-title>Antiproliferative mechanism of action of cryptophycin-52: Kinetic stabilization of microtubule dynamics by high-affinity binding to microtubule ends</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>1998</year><volume>95</volume><fpage>9313</fpage><lpage>9318</lpage><pub-id pub-id-type="doi">10.1073/pnas.95.16.9313</pub-id><?supplied-pmid 9689077?><pub-id pub-id-type="pmid">9689077</pub-id></element-citation></ref><ref id="B54-marinedrugs-17-00464"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sueyoshi</surname><given-names>K.</given-names></name><name><surname>Kaneda</surname><given-names>M.</given-names></name><name><surname>Sumimoto</surname><given-names>S.</given-names></name><name><surname>Oishi</surname><given-names>S.</given-names></name><name><surname>Fujii</surname><given-names>N.</given-names></name><name><surname>Suenaga</surname><given-names>K.</given-names></name><name><surname>Teruya</surname><given-names>T.</given-names></name></person-group><article-title>Odoamide, a cytotoxic cyclodepsipeptide from the marine cyanobacterium <italic>okeania</italic> sp.</article-title><source>Tetrahedron</source><year>2016</year><volume>72</volume><fpage>5472</fpage><lpage>5478</lpage><pub-id pub-id-type="doi">10.1016/j.tet.2016.07.031</pub-id></element-citation></ref><ref id="B55-marinedrugs-17-00464"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Le&#x000e3;o</surname><given-names>P.N.</given-names></name><name><surname>Costa</surname><given-names>M.</given-names></name><name><surname>Ramos</surname><given-names>V.</given-names></name><name><surname>Pereira</surname><given-names>A.R.</given-names></name><name><surname>Fernandes</surname><given-names>V.C.</given-names></name><name><surname>Domingues</surname><given-names>V.F.</given-names></name><name><surname>Gerwick</surname><given-names>W.H.</given-names></name><name><surname>Vasconcelos</surname><given-names>V.M.</given-names></name><name><surname>Martins</surname><given-names>R.</given-names></name></person-group><article-title>Antitumor activity of hierridin b, a cyanobacterial secondary metabolite found in both filamentous and unicellular marine strains</article-title><source>PLoS ONE</source><year>2013</year><volume>8</volume><elocation-id>e69562</elocation-id><pub-id pub-id-type="pmid">23922738</pub-id></element-citation></ref><ref id="B56-marinedrugs-17-00464"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abed</surname><given-names>R.M.</given-names></name><name><surname>Dobretsov</surname><given-names>S.</given-names></name><name><surname>Sudesh</surname><given-names>K.</given-names></name></person-group><article-title>Applications of cyanobacteria in biotechnology</article-title><source>J. Appl. Microbiol.</source><year>2009</year><volume>106</volume><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2672.2008.03918.x</pub-id><pub-id pub-id-type="pmid">19191979</pub-id></element-citation></ref><ref id="B57-marinedrugs-17-00464"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shishido</surname><given-names>T.K.</given-names></name><name><surname>Humisto</surname><given-names>A.</given-names></name><name><surname>Jokela</surname><given-names>J.</given-names></name><name><surname>Liu</surname><given-names>L.</given-names></name><name><surname>Wahlsten</surname><given-names>M.</given-names></name><name><surname>Tamrakar</surname><given-names>A.</given-names></name><name><surname>Fewer</surname><given-names>D.P.</given-names></name><name><surname>Permi</surname><given-names>P.</given-names></name><name><surname>Andreote</surname><given-names>A.P.</given-names></name><name><surname>Fiore</surname><given-names>M.F.</given-names></name></person-group><article-title>Antifungal compounds from cyanobacteria</article-title><source>Mar. Drugs</source><year>2015</year><volume>13</volume><fpage>2124</fpage><lpage>2140</lpage><pub-id pub-id-type="doi">10.3390/md13042124</pub-id><pub-id pub-id-type="pmid">25871291</pub-id></element-citation></ref><ref id="B58-marinedrugs-17-00464"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>MacMillan</surname><given-names>J.B.</given-names></name><name><surname>Molinski</surname><given-names>T.F.</given-names></name></person-group><article-title>Majusculoic acid, a brominated cyclopropyl fatty acid from a marine cyanobacterial mat assemblage</article-title><source>J. Nat. Prod.</source><year>2005</year><volume>68</volume><fpage>604</fpage><lpage>606</lpage><pub-id pub-id-type="doi">10.1021/np049596k</pub-id><pub-id pub-id-type="pmid">15844960</pub-id></element-citation></ref><ref id="B59-marinedrugs-17-00464"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sivakumar</surname><given-names>J.</given-names></name><name><surname>Santhanam</surname><given-names>P.</given-names></name></person-group><article-title>Antipathogenic activity of spirulina powder</article-title><source>Recent Res. Sci. Technol.</source><year>2011</year><volume>3</volume><fpage>158</fpage><lpage>161</lpage></element-citation></ref><ref id="B60-marinedrugs-17-00464"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clark</surname><given-names>B.R.</given-names></name><name><surname>Engene</surname><given-names>N.</given-names></name><name><surname>Teasdale</surname><given-names>M.E.</given-names></name><name><surname>Rowley</surname><given-names>D.C.</given-names></name><name><surname>Matainaho</surname><given-names>T.</given-names></name><name><surname>Valeriote</surname><given-names>F.A.</given-names></name><name><surname>Gerwick</surname><given-names>W.H.</given-names></name></person-group><article-title>Natural products chemistry and taxonomy of the marine cyanobacterium blennothrix cantharidosmum</article-title><source>J. Nat. Prod.</source><year>2008</year><volume>71</volume><fpage>1530</fpage><lpage>1537</lpage><pub-id pub-id-type="doi">10.1021/np800088a</pub-id><pub-id pub-id-type="pmid">18698821</pub-id></element-citation></ref><ref id="B61-marinedrugs-17-00464"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vining</surname><given-names>O.B.</given-names></name><name><surname>Medina</surname><given-names>R.A.</given-names></name><name><surname>Mitchell</surname><given-names>E.A.</given-names></name><name><surname>Videau</surname><given-names>P.</given-names></name><name><surname>Li</surname><given-names>D.</given-names></name><name><surname>Serrill</surname><given-names>J.D.</given-names></name><name><surname>Kelly</surname><given-names>J.X.</given-names></name><name><surname>Gerwick</surname><given-names>W.H.</given-names></name><name><surname>Proteau</surname><given-names>P.J.</given-names></name><name><surname>Ishmael</surname><given-names>J.E.</given-names></name></person-group><article-title>Depsipeptide companeramides from a panamanian marine cyanobacterium associated with the coibamide producer</article-title><source>J. Nat. Prod.</source><year>2015</year><volume>78</volume><fpage>413</fpage><lpage>420</lpage><pub-id pub-id-type="doi">10.1021/np5007907</pub-id><pub-id pub-id-type="pmid">25562664</pub-id></element-citation></ref><ref id="B62-marinedrugs-17-00464"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chai</surname><given-names>Q.-Y.</given-names></name><name><surname>Yang</surname><given-names>Z.</given-names></name><name><surname>Lin</surname><given-names>H.-W.</given-names></name><name><surname>Han</surname><given-names>B.-N.</given-names></name></person-group><article-title>Alkynyl-containing peptides of marine origin: A review</article-title><source>Mar. Drugs</source><year>2016</year><volume>14</volume><elocation-id>216</elocation-id><pub-id pub-id-type="doi">10.3390/md14110216</pub-id><?supplied-pmid 27886049?><pub-id pub-id-type="pmid">27886049</pub-id></element-citation></ref><ref id="B63-marinedrugs-17-00464"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Plav&#x00161;i&#x00107;</surname><given-names>M.</given-names></name><name><surname>Terzic</surname><given-names>S.</given-names></name><name><surname>Ahel</surname><given-names>M.</given-names></name><name><surname>Van Den Berg</surname><given-names>C.</given-names></name></person-group><article-title>Folic acid in coastal waters of the adriatic sea</article-title><source>Mar. Freshw. Res.</source><year>2003</year><volume>53</volume><fpage>1245</fpage><lpage>1252</lpage><pub-id pub-id-type="doi">10.1071/MF02044</pub-id></element-citation></ref><ref id="B64-marinedrugs-17-00464"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Villa</surname><given-names>F.A.</given-names></name><name><surname>Lieske</surname><given-names>K.</given-names></name><name><surname>Gerwick</surname><given-names>L.</given-names></name></person-group><article-title>Selective myd88-dependent pathway inhibition by the cyanobacterial natural product malyngamide f acetate</article-title><source>Eur. J. Pharmacol.</source><year>2010</year><volume>629</volume><fpage>140</fpage><lpage>146</lpage><pub-id pub-id-type="doi">10.1016/j.ejphar.2009.12.002</pub-id><?supplied-pmid 20006962?><pub-id pub-id-type="pmid">20006962</pub-id></element-citation></ref><ref id="B65-marinedrugs-17-00464"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Motuhi</surname><given-names>S.-E.</given-names></name><name><surname>Mehiri</surname><given-names>M.</given-names></name><name><surname>Payri</surname><given-names>C.</given-names></name><name><surname>La Barre</surname><given-names>S.</given-names></name><name><surname>Bach</surname><given-names>S.</given-names></name></person-group><article-title>Marine natural products from new caledonia&#x02014;A review</article-title><source>Mar. Drugs</source><year>2016</year><volume>14</volume><elocation-id>58</elocation-id><pub-id pub-id-type="doi">10.3390/md14030058</pub-id><?supplied-pmid 26999165?><pub-id pub-id-type="pmid">26999165</pub-id></element-citation></ref><ref id="B66-marinedrugs-17-00464"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leal</surname><given-names>M.C.</given-names></name><name><surname>Munro</surname><given-names>M.H.</given-names></name><name><surname>Blunt</surname><given-names>J.W.</given-names></name><name><surname>Puga</surname><given-names>J.</given-names></name><name><surname>Jesus</surname><given-names>B.</given-names></name><name><surname>Calado</surname><given-names>R.</given-names></name><name><surname>Rosa</surname><given-names>R.</given-names></name><name><surname>Madeira</surname><given-names>C.</given-names></name></person-group><article-title>Biogeography and biodiscovery hotspots of macroalgal marine natural products</article-title><source>Nat. Prod. Rep.</source><year>2013</year><volume>30</volume><fpage>1380</fpage><lpage>1390</lpage><pub-id pub-id-type="doi">10.1039/c3np70057g</pub-id><?supplied-pmid 23982267?><pub-id pub-id-type="pmid">23982267</pub-id></element-citation></ref><ref id="B67-marinedrugs-17-00464"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patra</surname><given-names>J.K.</given-names></name><name><surname>Lee</surname><given-names>S.W.</given-names></name><name><surname>Park</surname><given-names>J.G.</given-names></name><name><surname>Baek</surname><given-names>K.H.</given-names></name></person-group><article-title>Antioxidant and antibacterial properties of essential oil extracted from an edible seaweed undaria pinnatifida</article-title><source>J. Food Biochem.</source><year>2017</year><volume>41</volume><fpage>e12278</fpage><pub-id pub-id-type="doi">10.1111/jfbc.12278</pub-id></element-citation></ref><ref id="B68-marinedrugs-17-00464"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collins</surname><given-names>K.G.</given-names></name><name><surname>Fitzgerald</surname><given-names>G.F.</given-names></name><name><surname>Stanton</surname><given-names>C.</given-names></name><name><surname>Ross</surname><given-names>R.P.</given-names></name></person-group><article-title>Looking beyond the terrestrial: The potential of seaweed derived bioactives to treat non-communicable diseases</article-title><source>Mar. Drugs</source><year>2016</year><volume>14</volume><elocation-id>60</elocation-id><pub-id pub-id-type="doi">10.3390/md14030060</pub-id></element-citation></ref><ref id="B69-marinedrugs-17-00464"><label>69.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Taylor</surname><given-names>F.</given-names></name></person-group><source>Pharmacodynamic basis of herbal medicine</source><edition>2nd ed.</edition><publisher-name>CRC Press</publisher-name><publisher-loc>Boca Raton, FL, USA</publisher-loc><year>2006</year><fpage>699</fpage></element-citation></ref><ref id="B70-marinedrugs-17-00464"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vera</surname><given-names>J.</given-names></name><name><surname>Castro</surname><given-names>J.</given-names></name><name><surname>Gonzalez</surname><given-names>A.</given-names></name><name><surname>Moenne</surname><given-names>A.</given-names></name></person-group><article-title>Seaweed polysaccharides and derived oligosaccharides stimulate defense responses and protection against pathogens in plants</article-title><source>Mar. Drugs</source><year>2011</year><volume>9</volume><fpage>2514</fpage><lpage>2525</lpage><pub-id pub-id-type="doi">10.3390/md9122514</pub-id><pub-id pub-id-type="pmid">22363237</pub-id></element-citation></ref><ref id="B71-marinedrugs-17-00464"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>J.-B.</given-names></name><name><surname>Ohta</surname><given-names>Y.</given-names></name><name><surname>Hayashi</surname><given-names>K.</given-names></name><name><surname>Hayashi</surname><given-names>T.</given-names></name></person-group><article-title>Immunostimulating effects of a sulfated galactan from codium fragile</article-title><source>Carbohydr. Res.</source><year>2010</year><volume>345</volume><fpage>1452</fpage><lpage>1454</lpage><pub-id pub-id-type="doi">10.1016/j.carres.2010.02.026</pub-id><pub-id pub-id-type="pmid">20362278</pub-id></element-citation></ref><ref id="B72-marinedrugs-17-00464"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Souza</surname><given-names>&#x000c9;.T.</given-names></name><name><surname>Pereira de Lira</surname><given-names>D.</given-names></name><name><surname>Cavalcanti de Queiroz</surname><given-names>A.</given-names></name><name><surname>Costa da Silva</surname><given-names>D.J.</given-names></name><name><surname>Bezerra de Aquino</surname><given-names>A.</given-names></name><name><surname>Campessato Mella</surname><given-names>E.A.</given-names></name><name><surname>Prates Lorenzo</surname><given-names>V.</given-names></name><name><surname>De Miranda</surname><given-names>G.E.C.</given-names></name><name><surname>de Ara&#x000fa;jo-J&#x000fa;nior</surname><given-names>J.X.</given-names></name><name><surname>de Oliveira Chaves</surname><given-names>M.C.</given-names></name></person-group><article-title>The antinociceptive and anti-inflammatory activities of caulerpin, a bisindole alkaloid isolated from seaweeds of the genus caulerpa</article-title><source>Mar. Drugs</source><year>2009</year><volume>7</volume><fpage>689</fpage><lpage>704</lpage><pub-id pub-id-type="doi">10.3390/md7040689</pub-id><pub-id pub-id-type="pmid">20098607</pub-id></element-citation></ref><ref id="B73-marinedrugs-17-00464"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okai</surname><given-names>Y.</given-names></name><name><surname>Higashi-Okai</surname><given-names>K.</given-names></name></person-group><article-title>Potent anti-inflammatory activity of pheophytin a derived from edible green alga, enteromorpha prolifera (sujiao-nori)</article-title><source>Int. J. Immunopharmacol.</source><year>1997</year><volume>19</volume><fpage>355</fpage><lpage>358</lpage><pub-id pub-id-type="doi">10.1016/S0192-0561(97)00070-2</pub-id><pub-id pub-id-type="pmid">9467755</pub-id></element-citation></ref><ref id="B74-marinedrugs-17-00464"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wall</surname><given-names>M.E.</given-names></name><name><surname>Wani</surname><given-names>M.C.</given-names></name><name><surname>Manikumar</surname><given-names>G.</given-names></name><name><surname>Taylor</surname><given-names>H.</given-names></name><name><surname>Hughes</surname><given-names>T.J.</given-names></name><name><surname>Gaetano</surname><given-names>K.</given-names></name><name><surname>Gerwick</surname><given-names>W.H.</given-names></name><name><surname>McPhail</surname><given-names>A.T.</given-names></name><name><surname>McPhail</surname><given-names>D.R.</given-names></name></person-group><article-title>Plant antimutagenic agents 7. Structure and antimutagenic properties of cymobarbatol and 4-isocymbarbatol, new cymopols from green alga (cymopolia barbata)</article-title><source>J. Nat. Prod.</source><year>1989</year><volume>52</volume><fpage>1092</fpage><lpage>1099</lpage><pub-id pub-id-type="doi">10.1021/np50065a028</pub-id><?supplied-pmid 2691635?><pub-id pub-id-type="pmid">2691635</pub-id></element-citation></ref><ref id="B75-marinedrugs-17-00464"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smit</surname><given-names>A.J.</given-names></name></person-group><article-title>Medicinal and pharmaceutical uses of seaweed natural products: A review</article-title><source>J. Appl. Phycol.</source><year>2004</year><volume>16</volume><fpage>245</fpage><lpage>262</lpage><pub-id pub-id-type="doi">10.1023/B:JAPH.0000047783.36600.ef</pub-id></element-citation></ref><ref id="B76-marinedrugs-17-00464"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fischel</surname><given-names>J.</given-names></name><name><surname>Lemee</surname><given-names>R.</given-names></name><name><surname>Formento</surname><given-names>P.</given-names></name><name><surname>Caldani</surname><given-names>C.</given-names></name><name><surname>Moll</surname><given-names>J.</given-names></name><name><surname>Pesando</surname><given-names>D.</given-names></name><name><surname>Meinesz</surname><given-names>A.</given-names></name><name><surname>Grelier</surname><given-names>P.</given-names></name><name><surname>Pietra</surname><given-names>P.</given-names></name><name><surname>Guerriero</surname><given-names>A.</given-names></name></person-group><article-title>Cell growth inhibitory effects of caulerpenyne, a sesquiterpenoid from the marine algae caulerpa taxifolia</article-title><source>Anticancer Res.</source><year>1995</year><volume>15</volume><fpage>2155</fpage><lpage>2160</lpage><?supplied-pmid 8572617?><pub-id pub-id-type="pmid">8572617</pub-id></element-citation></ref><ref id="B77-marinedrugs-17-00464"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hosokawa</surname><given-names>M.</given-names></name><name><surname>Miyashita</surname><given-names>T.</given-names></name><name><surname>Nishikawa</surname><given-names>S.</given-names></name><name><surname>Emi</surname><given-names>S.</given-names></name><name><surname>Tsukui</surname><given-names>T.</given-names></name><name><surname>Beppu</surname><given-names>F.</given-names></name><name><surname>Okada</surname><given-names>T.</given-names></name><name><surname>Miyashita</surname><given-names>K.</given-names></name></person-group><article-title>Fucoxanthin regulates adipocytokine mrna expression in white adipose tissue of diabetic/obese kk-ay mice</article-title><source>Arch. Biochem. Biophys.</source><year>2010</year><volume>504</volume><fpage>17</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1016/j.abb.2010.05.031</pub-id><?supplied-pmid 20515643?><pub-id pub-id-type="pmid">20515643</pub-id></element-citation></ref><ref id="B78-marinedrugs-17-00464"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>J.-B.</given-names></name><name><surname>Koizumi</surname><given-names>S.</given-names></name><name><surname>Hayashi</surname><given-names>K.</given-names></name><name><surname>Hayashi</surname><given-names>T.</given-names></name></person-group><article-title>Structure of rhamnan sulfate from the green alga monostroma nitidum and its anti-herpetic effect</article-title><source>Carbohydr. Polym.</source><year>2010</year><volume>81</volume><fpage>572</fpage><lpage>577</lpage><pub-id pub-id-type="doi">10.1016/j.carbpol.2010.03.014</pub-id></element-citation></ref><ref id="B79-marinedrugs-17-00464"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Xiao</surname><given-names>X.</given-names></name><name><surname>Conte</surname><given-names>M.M.</given-names></name><name><surname>Khalil</surname><given-names>Z.</given-names></name><name><surname>Capon</surname><given-names>R.J.</given-names></name></person-group><article-title>Spiralisones a&#x02013;d: Acylphloroglucinol hemiketals from an australian marine brown alga, zonaria spiralis</article-title><source>Org. Biomol. Chem.</source><year>2012</year><volume>10</volume><fpage>9671</fpage><lpage>9676</lpage><pub-id pub-id-type="doi">10.1039/c2ob26988k</pub-id><pub-id pub-id-type="pmid">23147836</pub-id></element-citation></ref><ref id="B80-marinedrugs-17-00464"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>B.W.</given-names></name><name><surname>Ryu</surname><given-names>G.</given-names></name><name><surname>Park</surname><given-names>S.H.</given-names></name><name><surname>Kim</surname><given-names>E.S.</given-names></name><name><surname>Shin</surname><given-names>J.</given-names></name><name><surname>Roh</surname><given-names>S.S.</given-names></name><name><surname>Shin</surname><given-names>H.C.</given-names></name><name><surname>Lee</surname><given-names>B.H.</given-names></name></person-group><article-title>Anticholinesterase activity of plastoquinones from sargassum sagamianum: Lead compounds for alzheimer&#x02019;s disease therapy</article-title><source>Phytother. Res.</source><year>2007</year><volume>21</volume><fpage>423</fpage><lpage>426</lpage><pub-id pub-id-type="doi">10.1002/ptr.2090</pub-id><pub-id pub-id-type="pmid">17236179</pub-id></element-citation></ref><ref id="B81-marinedrugs-17-00464"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rahelivao</surname><given-names>M.</given-names></name><name><surname>Gruner</surname><given-names>M.</given-names></name><name><surname>Andriamanantoanina</surname><given-names>H.</given-names></name><name><surname>Andriamihaja</surname><given-names>B.</given-names></name><name><surname>Bauer</surname><given-names>I.</given-names></name><name><surname>Kn&#x000f6;lker</surname><given-names>H.-J.</given-names></name></person-group><article-title>Red algae (rhodophyta) from the coast of madagascar: Preliminary bioactivity studies and isolation of natural products</article-title><source>Mar. Drugs</source><year>2015</year><volume>13</volume><fpage>4197</fpage><lpage>4216</lpage><pub-id pub-id-type="doi">10.3390/md13074197</pub-id><pub-id pub-id-type="pmid">26198236</pub-id></element-citation></ref><ref id="B82-marinedrugs-17-00464"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Makkar</surname><given-names>F.</given-names></name><name><surname>Chakraborty</surname><given-names>K.</given-names></name></person-group><article-title>Previously undescribed antioxidative azocinyl morpholinone alkaloid from red seaweed gracilaria opuntia with anti-cyclooxygenase and lipoxygenase properties</article-title><source>Nat. Prod. Res.</source><year>2018</year><volume>32</volume><fpage>1150</fpage><lpage>1160</lpage><pub-id pub-id-type="doi">10.1080/14786419.2017.1326041</pub-id><pub-id pub-id-type="pmid">28482695</pub-id></element-citation></ref><ref id="B83-marinedrugs-17-00464"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ren</surname><given-names>D.</given-names></name><name><surname>Wood</surname><given-names>T.K.</given-names></name></person-group><article-title>(5z)-4-bromo-5-(bromomethylene)-3-butyl-2 (5h)-furanone reduces corrosion from desulfotomaculum orientis</article-title><source>Environ. Microbiol.</source><year>2004</year><volume>6</volume><fpage>535</fpage><lpage>540</lpage><pub-id pub-id-type="doi">10.1111/j.1462-2920.2004.00587.x</pub-id><?supplied-pmid 15049927?><pub-id pub-id-type="pmid">15049927</pub-id></element-citation></ref><ref id="B84-marinedrugs-17-00464"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haefner</surname><given-names>B.</given-names></name></person-group><article-title>Drugs from the deep: Marine natural products as drug candidates</article-title><source>Drug Discov. Today</source><year>2003</year><volume>8</volume><fpage>536</fpage><lpage>544</lpage><pub-id pub-id-type="doi">10.1016/S1359-6446(03)02713-2</pub-id><pub-id pub-id-type="pmid">12821301</pub-id></element-citation></ref><ref id="B85-marinedrugs-17-00464"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamman</surname><given-names>M.T.</given-names></name><name><surname>Otto</surname><given-names>C.S.</given-names></name><name><surname>Scheuer</surname><given-names>P.J.</given-names></name><name><surname>Dunbar</surname><given-names>D.C.</given-names></name></person-group><article-title>Kahalalides: Bioactive peptides from a marine mollusk elysia rufescens and its algal diet bryopsis sp.</article-title><source>J. Org. Chem.</source><year>1998</year><volume>63</volume><fpage>4856</fpage><pub-id pub-id-type="doi">10.1021/jo984009j</pub-id></element-citation></ref><ref id="B86-marinedrugs-17-00464"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamed</surname><given-names>I.</given-names></name><name><surname>&#x000d6;zogul</surname><given-names>F.</given-names></name><name><surname>&#x000d6;zogul</surname><given-names>Y.</given-names></name><name><surname>Regenstein</surname><given-names>J.M.</given-names></name></person-group><article-title>Marine bioactive compounds and their health benefits: A review</article-title><source>Compr. Rev. Food Sci. Food Saf.</source><year>2015</year><volume>14</volume><fpage>446</fpage><lpage>465</lpage><pub-id pub-id-type="doi">10.1111/1541-4337.12136</pub-id></element-citation></ref><ref id="B87-marinedrugs-17-00464"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prajapati</surname><given-names>V.D.</given-names></name><name><surname>Maheriya</surname><given-names>P.M.</given-names></name><name><surname>Jani</surname><given-names>G.K.</given-names></name><name><surname>Solanki</surname><given-names>H.K.</given-names></name></person-group><article-title>Carrageenan: A natural seaweed polysaccharide and its applications</article-title><source>Carbohydr. Polym.</source><year>2014</year><volume>105</volume><fpage>97</fpage><lpage>112</lpage><pub-id pub-id-type="doi">10.1016/j.carbpol.2014.01.067</pub-id><?supplied-pmid 24708958?><pub-id pub-id-type="pmid">24708958</pub-id></element-citation></ref><ref id="B88-marinedrugs-17-00464"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Houck</surname><given-names>J.</given-names></name><name><surname>Bhayana</surname><given-names>J.</given-names></name><name><surname>Lee</surname><given-names>T.</given-names></name></person-group><article-title>The inhibition of pepsin and peptic ulcers</article-title><source>Gastroenterology</source><year>1960</year><volume>39</volume><fpage>196</fpage><pub-id pub-id-type="doi">10.1016/S0016-5085(19)35294-1</pub-id><pub-id pub-id-type="pmid">14403337</pub-id></element-citation></ref><ref id="B89-marinedrugs-17-00464"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahmadi</surname><given-names>A.</given-names></name><name><surname>Zorofchian Moghadamtousi</surname><given-names>S.</given-names></name><name><surname>Abubakar</surname><given-names>S.</given-names></name><name><surname>Zandi</surname><given-names>K.</given-names></name></person-group><article-title>Antiviral potential of algae polysaccharides isolated from marine sources: A review</article-title><source>BioMed Res. Int.</source><year>2015</year><volume>2015</volume><pub-id pub-id-type="doi">10.1155/2015/825203</pub-id></element-citation></ref><ref id="B90-marinedrugs-17-00464"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pushpamali</surname><given-names>W.A.</given-names></name><name><surname>Nikapitiya</surname><given-names>C.</given-names></name><name><surname>De Zoysa</surname><given-names>M.</given-names></name><name><surname>Whang</surname><given-names>I.</given-names></name><name><surname>Kim</surname><given-names>S.J.</given-names></name><name><surname>Lee</surname><given-names>J.</given-names></name></person-group><article-title>Isolation and purification of an anticoagulant from fermented red seaweed lomentaria catenata</article-title><source>Carbohydr. Polym.</source><year>2008</year><volume>73</volume><fpage>274</fpage><lpage>279</lpage><pub-id pub-id-type="doi">10.1016/j.carbpol.2007.11.029</pub-id></element-citation></ref><ref id="B91-marinedrugs-17-00464"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deepa</surname><given-names>S.</given-names></name><name><surname>Bhuvana</surname><given-names>B.</given-names></name><name><surname>Hemamalini</surname><given-names>S.</given-names></name><name><surname>Janet</surname><given-names>C.</given-names></name><name><surname>Kumar</surname><given-names>S.</given-names></name></person-group><article-title>Therapeutic potential and pharmacological significance of the marine algae gracilaria corticata</article-title><source>Pharm. Biol. Eval.</source><year>2017</year><volume>4</volume><fpage>68</fpage><lpage>72</lpage></element-citation></ref><ref id="B92-marinedrugs-17-00464"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yasoda</surname><given-names>H.N.</given-names></name><name><surname>Chi</surname><given-names>Z.</given-names></name><name><surname>Zhu</surname><given-names>K.</given-names></name></person-group><article-title>Probiotics and sea cucumber farming</article-title><source>SPC Bechedemer Inf. Bull.</source><year>2006</year><volume>24</volume><fpage>45</fpage></element-citation></ref><ref id="B93-marinedrugs-17-00464"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kurihara</surname><given-names>H.</given-names></name><name><surname>Kagawa</surname><given-names>Y.</given-names></name><name><surname>Konno</surname><given-names>R.</given-names></name><name><surname>Kim</surname><given-names>S.M.</given-names></name><name><surname>Takahashi</surname><given-names>K.</given-names></name></person-group><article-title>Lipoxygenase inhibitors derived from marine macroalgae</article-title><source>Bioorg. Med. Chem. Lett.</source><year>2014</year><volume>24</volume><fpage>1383</fpage><lpage>1385</lpage><pub-id pub-id-type="doi">10.1016/j.bmcl.2014.01.046</pub-id><?supplied-pmid 24495846?><pub-id pub-id-type="pmid">24495846</pub-id></element-citation></ref><ref id="B94-marinedrugs-17-00464"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Witvrouw</surname><given-names>M.</given-names></name><name><surname>Este</surname><given-names>J.</given-names></name><name><surname>Mateu</surname><given-names>M.</given-names></name><name><surname>Reymen</surname><given-names>D.</given-names></name><name><surname>Andrei</surname><given-names>G.</given-names></name><name><surname>Snoeck</surname><given-names>R.</given-names></name><name><surname>Ikeda</surname><given-names>S.</given-names></name><name><surname>Pauwels</surname><given-names>R.</given-names></name><name><surname>Bianchini</surname><given-names>N.V.</given-names></name><name><surname>Desmyter</surname><given-names>J.</given-names></name></person-group><article-title>Activity of a sulfated polysaccharide extracted from the red seaweed aghardhiella tenera against human immunodeficiency virus and other enveloped viruses</article-title><source>Antivir. Chem. Chemother.</source><year>1994</year><volume>5</volume><fpage>297</fpage><lpage>303</lpage><pub-id pub-id-type="doi">10.1177/095632029400500503</pub-id></element-citation></ref><ref id="B95-marinedrugs-17-00464"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Devi</surname><given-names>K.P.</given-names></name><name><surname>Suganthy</surname><given-names>N.</given-names></name><name><surname>Kesika</surname><given-names>P.</given-names></name><name><surname>Pandian</surname><given-names>S.K.</given-names></name></person-group><article-title>Bioprotective properties of seaweeds: In vitro evaluation of antioxidant activity and antimicrobial activity against food borne bacteria in relation to polyphenolic content</article-title><source>BMC Complement. Altern. Med.</source><year>2008</year><volume>8</volume><elocation-id>38</elocation-id><pub-id pub-id-type="doi">10.1186/1472-6882-8-38</pub-id><?supplied-pmid 18613983?><pub-id pub-id-type="pmid">18613983</pub-id></element-citation></ref><ref id="B96-marinedrugs-17-00464"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mandal</surname><given-names>P.</given-names></name><name><surname>Pujol</surname><given-names>C.A.</given-names></name><name><surname>Carlucci</surname><given-names>M.J.</given-names></name><name><surname>Chattopadhyay</surname><given-names>K.</given-names></name><name><surname>Damonte</surname><given-names>E.B.</given-names></name><name><surname>Ray</surname><given-names>B.</given-names></name></person-group><article-title>Anti-herpetic activity of a sulfated xylomannan from scinaia hatei</article-title><source>Phytochemistry</source><year>2008</year><volume>69</volume><fpage>2193</fpage><lpage>2199</lpage><pub-id pub-id-type="doi">10.1016/j.phytochem.2008.05.004</pub-id><?supplied-pmid 18572208?><pub-id pub-id-type="pmid">18572208</pub-id></element-citation></ref><ref id="B97-marinedrugs-17-00464"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bouhlal</surname><given-names>R.</given-names></name><name><surname>Haslin</surname><given-names>C.</given-names></name><name><surname>Chermann</surname><given-names>J.-C.</given-names></name><name><surname>Colliec-Jouault</surname><given-names>S.</given-names></name><name><surname>Sinquin</surname><given-names>C.</given-names></name><name><surname>Simon</surname><given-names>G.</given-names></name><name><surname>Cerantola</surname><given-names>S.</given-names></name><name><surname>Riadi</surname><given-names>H.</given-names></name><name><surname>Bourgougnon</surname><given-names>N.</given-names></name></person-group><article-title>Antiviral activities of sulfated polysaccharides isolated from sphaerococcus coronopifolius (rhodophytha, gigartinales) and boergeseniella thuyoides (rhodophyta, ceramiales)</article-title><source>Mar. Drugs</source><year>2011</year><volume>9</volume><fpage>1187</fpage><lpage>1209</lpage><pub-id pub-id-type="doi">10.3390/md9071187</pub-id><?supplied-pmid 21822410?><pub-id pub-id-type="pmid">21822410</pub-id></element-citation></ref><ref id="B98-marinedrugs-17-00464"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Serkedjieva</surname><given-names>J.</given-names></name></person-group><article-title>Antiviral activity of the red marine alga ceramium rubrum</article-title><source>Phytother. Res.</source><year>2004</year><volume>18</volume><fpage>480</fpage><lpage>483</lpage><pub-id pub-id-type="doi">10.1002/ptr.1458</pub-id><pub-id pub-id-type="pmid">15287074</pub-id></element-citation></ref><ref id="B99-marinedrugs-17-00464"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heo</surname><given-names>S.-J.</given-names></name><name><surname>Cha</surname><given-names>S.-H.</given-names></name><name><surname>Lee</surname><given-names>K.-W.</given-names></name><name><surname>Jeon</surname><given-names>Y.-J.</given-names></name></person-group><article-title>Antioxidant activities of red algae from jeju island</article-title><source>Algae</source><year>2006</year><volume>21</volume><fpage>149</fpage><lpage>156</lpage><pub-id pub-id-type="doi">10.4490/ALGAE.2006.21.1.149</pub-id></element-citation></ref><ref id="B100-marinedrugs-17-00464"><label>100.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nogueira</surname><given-names>C.C.R.</given-names></name><name><surname>de Palmer Paix&#x000e3;o</surname><given-names>I.C.N.</given-names></name><name><surname>Teixeira</surname><given-names>V.L.</given-names></name></person-group><article-title>Antioxidant activity of natural products isolated from red seaweeds</article-title><source>Nat. Prod. Commun.</source><year>2014</year><volume>9</volume><fpage>1934578X1400900737</fpage><pub-id pub-id-type="doi">10.1177/1934578X1400900737</pub-id></element-citation></ref><ref id="B101-marinedrugs-17-00464"><label>101.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yeh</surname><given-names>C.-C.</given-names></name><name><surname>Tseng</surname><given-names>C.-N.</given-names></name><name><surname>Yang</surname><given-names>J.-I.</given-names></name><name><surname>Huang</surname><given-names>H.-W.</given-names></name><name><surname>Fang</surname><given-names>Y.</given-names></name><name><surname>Tang</surname><given-names>J.-Y.</given-names></name><name><surname>Chang</surname><given-names>F.-R.</given-names></name><name><surname>Chang</surname><given-names>H.-W.</given-names></name></person-group><article-title>Antiproliferation and induction of apoptosis in ca9-22 oral cancer cells by ethanolic extract of gracilaria tenuistipitata</article-title><source>Molecules</source><year>2012</year><volume>17</volume><fpage>10916</fpage><lpage>10927</lpage><pub-id pub-id-type="doi">10.3390/molecules170910916</pub-id><pub-id pub-id-type="pmid">22968475</pub-id></element-citation></ref><ref id="B102-marinedrugs-17-00464"><label>102.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yeh</surname><given-names>C.-C.</given-names></name><name><surname>Yang</surname><given-names>J.-I.</given-names></name><name><surname>Lee</surname><given-names>J.-C.</given-names></name><name><surname>Tseng</surname><given-names>C.-N.</given-names></name><name><surname>Chan</surname><given-names>Y.-C.</given-names></name><name><surname>Hseu</surname><given-names>Y.-C.</given-names></name><name><surname>Tang</surname><given-names>J.-Y.</given-names></name><name><surname>Chuang</surname><given-names>L.-Y.</given-names></name><name><surname>Huang</surname><given-names>H.-W.</given-names></name><name><surname>Chang</surname><given-names>F.-R.</given-names></name></person-group><article-title>Anti-proliferative effect of methanolic extract of gracilaria tenuistipitata on oral cancer cells involves apoptosis, DNA damage, and oxidative stress</article-title><source>BMC Complement. Alternat. Med.</source><year>2012</year><volume>12</volume><elocation-id>142</elocation-id><pub-id pub-id-type="doi">10.1186/1472-6882-12-142</pub-id></element-citation></ref><ref id="B103-marinedrugs-17-00464"><label>103.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smyrniotopoulos</surname><given-names>V.</given-names></name><name><surname>Vagias</surname><given-names>C.</given-names></name><name><surname>Rahman</surname><given-names>M.M.</given-names></name><name><surname>Gibbons</surname><given-names>S.</given-names></name><name><surname>Roussis</surname><given-names>V.</given-names></name></person-group><article-title>Structure and antibacterial activity of brominated diterpenes from the red alga sphaerococcus coronopifolius</article-title><source>Chem. biodivers.</source><year>2010</year><volume>7</volume><fpage>186</fpage><lpage>195</lpage><pub-id pub-id-type="doi">10.1002/cbdv.200800309</pub-id><?supplied-pmid 20087985?><pub-id pub-id-type="pmid">20087985</pub-id></element-citation></ref><ref id="B104-marinedrugs-17-00464"><label>104.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>P&#x000e9;rez</surname><given-names>M.</given-names></name><name><surname>Falqu&#x000e9;</surname><given-names>E.</given-names></name><name><surname>Dom&#x000ed;nguez</surname><given-names>H.</given-names></name></person-group><article-title>Antimicrobial action of compounds from marine seaweed</article-title><source>Mar. Drugs</source><year>2016</year><volume>14</volume><elocation-id>52</elocation-id><pub-id pub-id-type="doi">10.3390/md14030052</pub-id><?supplied-pmid 27005637?><pub-id pub-id-type="pmid">27005637</pub-id></element-citation></ref><ref id="B105-marinedrugs-17-00464"><label>105.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shalaby</surname><given-names>E.</given-names></name></person-group><article-title>Algae as promising organisms for environment and health</article-title><source>Plant Signal. Behav.</source><year>2011</year><volume>6</volume><fpage>1338</fpage><lpage>1350</lpage><pub-id pub-id-type="doi">10.4161/psb.6.9.16779</pub-id><?supplied-pmid 21862867?><pub-id pub-id-type="pmid">21862867</pub-id></element-citation></ref><ref id="B106-marinedrugs-17-00464"><label>106.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sotokawa</surname><given-names>T.</given-names></name><name><surname>Noda</surname><given-names>T.</given-names></name><name><surname>Pi</surname><given-names>S.</given-names></name><name><surname>Hirama</surname><given-names>M.</given-names></name></person-group><article-title>A three-step synthesis of halomon</article-title><source>Angew. Chem. Int. Ed.</source><year>2000</year><volume>39</volume><fpage>3430</fpage><lpage>3432</lpage><pub-id pub-id-type="doi">10.1002/1521-3773(20001002)39:19&#x0003c;3430::AID-ANIE3430&#x0003e;3.0.CO;2-3</pub-id></element-citation></ref><ref id="B107-marinedrugs-17-00464"><label>107.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andrianasolo</surname><given-names>E.H.</given-names></name><name><surname>France</surname><given-names>D.</given-names></name><name><surname>Cornell-Kennon</surname><given-names>S.</given-names></name><name><surname>Gerwick</surname><given-names>W.H.</given-names></name></person-group><article-title>DNA methyl transferase inhibiting halogenated monoterpenes from the madagascar red marine alga portieria h ornemannii</article-title><source>J. Nat. Prod.</source><year>2006</year><volume>69</volume><fpage>576</fpage><lpage>579</lpage><pub-id pub-id-type="doi">10.1021/np0503956</pub-id><?supplied-pmid 16643029?><pub-id pub-id-type="pmid">16643029</pub-id></element-citation></ref><ref id="B108-marinedrugs-17-00464"><label>108.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Groth</surname><given-names>I.</given-names></name><name><surname>Gr&#x000fc;newald</surname><given-names>N.</given-names></name><name><surname>Alban</surname><given-names>S.</given-names></name></person-group><article-title>Pharmacological profiles of animal-and nonanimal-derived sulfated polysaccharides&#x02013;comparison of unfractionated heparin, the semisynthetic glucan sulfate ps3, and the sulfated polysaccharide fraction isolated from delesseria sanguinea</article-title><source>Glycobiology</source><year>2008</year><volume>19</volume><fpage>408</fpage><lpage>417</lpage><pub-id pub-id-type="doi">10.1093/glycob/cwn151</pub-id><?supplied-pmid 19106233?><pub-id pub-id-type="pmid">19106233</pub-id></element-citation></ref><ref id="B109-marinedrugs-17-00464"><label>109.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farias</surname><given-names>W.R.</given-names></name><name><surname>Valente</surname><given-names>A.-P.</given-names></name><name><surname>Pereira</surname><given-names>M.S.</given-names></name><name><surname>Mour&#x000e3;o</surname><given-names>P.A.</given-names></name></person-group><article-title>Structure and anticoagulant activity of sulfated galactans isolation of a unique sulfated galactan from the red algaebotryocladia occidentalis and comparison of its anticoagulant action with that of sulfated galactans from invertebrates</article-title><source>J. Biol. Chem.</source><year>2000</year><volume>275</volume><fpage>29299</fpage><lpage>29307</lpage><pub-id pub-id-type="doi">10.1074/jbc.M002422200</pub-id><pub-id pub-id-type="pmid">10882718</pub-id></element-citation></ref><ref id="B110-marinedrugs-17-00464"><label>110.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsuhiro</surname><given-names>B.</given-names></name><name><surname>Conte</surname><given-names>A.F.</given-names></name><name><surname>Damonte</surname><given-names>E.B.</given-names></name><name><surname>Kolender</surname><given-names>A.A.</given-names></name><name><surname>Matulewicz</surname><given-names>M.C.</given-names></name><name><surname>Mej&#x000ed;as</surname><given-names>E.G.</given-names></name><name><surname>Pujol</surname><given-names>C.A.</given-names></name><name><surname>Z&#x000fa;&#x000f1;iga</surname><given-names>E.A.</given-names></name></person-group><article-title>Structural analysis and antiviral activity of a sulfated galactan from the red seaweed schizymenia binderi (gigartinales, rhodophyta)</article-title><source>Carbohydr. Res.</source><year>2005</year><volume>340</volume><fpage>2392</fpage><lpage>2402</lpage><pub-id pub-id-type="doi">10.1016/j.carres.2005.08.004</pub-id><pub-id pub-id-type="pmid">16125685</pub-id></element-citation></ref><ref id="B111-marinedrugs-17-00464"><label>111.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faulkner</surname><given-names>D.J.</given-names></name></person-group><article-title>Marine natural products</article-title><source>Nat. Prod. Rep.</source><year>2001</year><volume>18</volume><fpage>1R</fpage><lpage>49R</lpage><pub-id pub-id-type="doi">10.1039/b006897g</pub-id><pub-id pub-id-type="pmid">11245399</pub-id></element-citation></ref><ref id="B112-marinedrugs-17-00464"><label>112.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haugan</surname><given-names>J.A.</given-names></name></person-group><article-title>Algal carotenoids 54. Carotenoids of brown algae (phaeophyceae)</article-title><source>Biochem. Syst. Ecol.</source><year>1994</year><volume>22</volume><fpage>31</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.1016/0305-1978(94)90112-0</pub-id></element-citation></ref><ref id="B113-marinedrugs-17-00464"><label>113.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D&#x02019;Orazio</surname><given-names>N.</given-names></name><name><surname>Gemello</surname><given-names>E.</given-names></name><name><surname>Gammone</surname><given-names>M.A.</given-names></name><name><surname>de Girolamo</surname><given-names>M.</given-names></name><name><surname>Ficoneri</surname><given-names>C.</given-names></name><name><surname>Riccioni</surname><given-names>G.</given-names></name></person-group><article-title>Fucoxantin: A treasure from the sea</article-title><source>Mar. Drugs</source><year>2012</year><volume>10</volume><fpage>604</fpage><lpage>616</lpage><pub-id pub-id-type="doi">10.3390/md10030604</pub-id><?supplied-pmid 22611357?><pub-id pub-id-type="pmid">22611357</pub-id></element-citation></ref><ref id="B114-marinedrugs-17-00464"><label>114.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Piper</surname><given-names>R.</given-names></name></person-group><source>Extraordinary animals: An Encyclopedia of Curious and Unusual Animals</source><publisher-name>Greenwood Publishing Group</publisher-name><publisher-loc>London, UK</publisher-loc><year>2007</year><fpage>320</fpage></element-citation></ref><ref id="B115-marinedrugs-17-00464"><label>115.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Pang</surname><given-names>Z.</given-names></name><name><surname>Han</surname><given-names>C.</given-names></name></person-group><article-title>Undaria pinnatifida (wakame): A seaweed with pharmacological properties</article-title><source>Sci. Int.</source><year>2014</year><volume>2</volume><fpage>32</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.17311/sciintl.2014.32.36</pub-id></element-citation></ref><ref id="B116-marinedrugs-17-00464"><label>116.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khan</surname><given-names>M.N.A.</given-names></name><name><surname>Cho</surname><given-names>J.-Y.</given-names></name><name><surname>Lee</surname><given-names>M.-C.</given-names></name><name><surname>Kang</surname><given-names>J.-Y.</given-names></name><name><surname>Park</surname><given-names>N.G.</given-names></name><name><surname>Fujii</surname><given-names>H.</given-names></name><name><surname>Hong</surname><given-names>Y.-K.</given-names></name></person-group><article-title>Isolation of two anti-inflammatory and one pro-inflammatory polyunsaturated fatty acids from the brown seaweed undaria pinnatifida</article-title><source>J. Agric. Food Chem.</source><year>2007</year><volume>55</volume><fpage>6984</fpage><lpage>6988</lpage><pub-id pub-id-type="doi">10.1021/jf071791s</pub-id><?supplied-pmid 17665931?><pub-id pub-id-type="pmid">17665931</pub-id></element-citation></ref><ref id="B117-marinedrugs-17-00464"><label>117.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>M.-K.</given-names></name><name><surname>Jung</surname><given-names>U.</given-names></name><name><surname>Roh</surname><given-names>C.</given-names></name></person-group><article-title>Fucoidan from marine brown algae inhibits lipid accumulation</article-title><source>Mar. Drugs</source><year>2011</year><volume>9</volume><fpage>1359</fpage><lpage>1367</lpage><pub-id pub-id-type="doi">10.3390/md9081359</pub-id><?supplied-pmid 21892350?><pub-id pub-id-type="pmid">21892350</pub-id></element-citation></ref><ref id="B118-marinedrugs-17-00464"><label>118.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spavieri</surname><given-names>J.</given-names></name><name><surname>Allmendinger</surname><given-names>A.</given-names></name><name><surname>Kaiser</surname><given-names>M.</given-names></name><name><surname>Casey</surname><given-names>R.</given-names></name><name><surname>Hingley-Wilson</surname><given-names>S.</given-names></name><name><surname>Lalvani</surname><given-names>A.</given-names></name><name><surname>Guiry</surname><given-names>M.D.</given-names></name><name><surname>Blunden</surname><given-names>G.</given-names></name><name><surname>Tasdemir</surname><given-names>D.</given-names></name></person-group><article-title>Antimycobacterial, antiprotozoal and cytotoxic potential of twenty-one brown algae (phaeophyceae) from british and irish waters</article-title><source>Phytother. Res.</source><year>2010</year><volume>24</volume><fpage>1724</fpage><lpage>1729</lpage><pub-id pub-id-type="doi">10.1002/ptr.3208</pub-id><?supplied-pmid 20564461?><pub-id pub-id-type="pmid">20564461</pub-id></element-citation></ref><ref id="B119-marinedrugs-17-00464"><label>119.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lutay</surname><given-names>N.</given-names></name><name><surname>Nilsson</surname><given-names>I.</given-names></name><name><surname>Wadstr&#x000f6;m</surname><given-names>T.</given-names></name><name><surname>Ljungh</surname><given-names>&#x000c5;.</given-names></name></person-group><article-title>Effect of heparin, fucoidan and other polysaccharides on adhesion of enterohepatic helicobacter species to murine macrophages</article-title><source>Appl. Biochem. Biotechnol.</source><year>2011</year><volume>164</volume><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1007/s12010-010-9109-7</pub-id><?supplied-pmid 21088929?><pub-id pub-id-type="pmid">21088929</pub-id></element-citation></ref><ref id="B120-marinedrugs-17-00464"><label>120.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ale</surname><given-names>M.T.</given-names></name><name><surname>Maruyama</surname><given-names>H.</given-names></name><name><surname>Tamauchi</surname><given-names>H.</given-names></name><name><surname>Mikkelsen</surname><given-names>J.D.</given-names></name><name><surname>Meyer</surname><given-names>A.S.</given-names></name></person-group><article-title>Fucoidan from sargassum sp. And fucus vesiculosus reduces cell viability of lung carcinoma and melanoma cells in vitro and activates natural killer cells in mice in vivo</article-title><source>Int. J. Biol. Macromol.</source><year>2011</year><volume>49</volume><fpage>331</fpage><lpage>336</lpage><pub-id pub-id-type="doi">10.1016/j.ijbiomac.2011.05.009</pub-id><pub-id pub-id-type="pmid">21624396</pub-id></element-citation></ref><ref id="B121-marinedrugs-17-00464"><label>121.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salgado</surname><given-names>L.T.</given-names></name><name><surname>Tomazetto</surname><given-names>R.</given-names></name><name><surname>Cinelli</surname><given-names>L.P.</given-names></name><name><surname>Farina</surname><given-names>M.</given-names></name><name><surname>Amado Filho</surname><given-names>G.M.</given-names></name></person-group><article-title>The influence of brown algae alginates on phenolic compounds capability of ultraviolet radiation absorption in vitro</article-title><source>Braz. J. Oceanogr.</source><year>2007</year><volume>55</volume><fpage>145</fpage><lpage>154</lpage><pub-id pub-id-type="doi">10.1590/S1679-87592007000200007</pub-id></element-citation></ref><ref id="B122-marinedrugs-17-00464"><label>122.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>M.-C.</given-names></name><name><surname>Wijesinghe</surname><given-names>W.</given-names></name><name><surname>Lee</surname><given-names>S.-H.</given-names></name><name><surname>Kang</surname><given-names>S.-M.</given-names></name><name><surname>Ko</surname><given-names>S.-C.</given-names></name><name><surname>Yang</surname><given-names>X.</given-names></name><name><surname>Kang</surname><given-names>N.</given-names></name><name><surname>Jeon</surname><given-names>B.-T.</given-names></name><name><surname>Kim</surname><given-names>J.</given-names></name><name><surname>Lee</surname><given-names>D.-H.</given-names></name></person-group><article-title>Dieckol isolated from brown seaweed ecklonia cava attenuates type &#x00456;&#x00456; diabetes in db/db mouse model</article-title><source>Food Chem. Toxicol.</source><year>2013</year><volume>53</volume><fpage>294</fpage><lpage>298</lpage><pub-id pub-id-type="doi">10.1016/j.fct.2012.12.012</pub-id><?supplied-pmid 23261675?></element-citation></ref><ref id="B123-marinedrugs-17-00464"><label>123.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moubayed</surname><given-names>N.M.</given-names></name><name><surname>Al Houri</surname><given-names>H.J.</given-names></name><name><surname>Al Khulaifi</surname><given-names>M.M.</given-names></name><name><surname>Al Farraj</surname><given-names>D.A.</given-names></name></person-group><article-title>Antimicrobial, antioxidant properties and chemical composition of seaweeds collected from saudi arabia (red sea and arabian gulf)</article-title><source>Saudi J. Biol. Sci.</source><year>2017</year><volume>24</volume><fpage>162</fpage><lpage>169</lpage><pub-id pub-id-type="doi">10.1016/j.sjbs.2016.05.018</pub-id><?supplied-pmid 28053587?><pub-id pub-id-type="pmid">28053587</pub-id></element-citation></ref><ref id="B124-marinedrugs-17-00464"><label>124.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rengasamy</surname><given-names>K.R.</given-names></name><name><surname>Aderogba</surname><given-names>M.A.</given-names></name><name><surname>Amoo</surname><given-names>S.O.</given-names></name><name><surname>Stirk</surname><given-names>W.A.</given-names></name><name><surname>Van Staden</surname><given-names>J.</given-names></name></person-group><article-title>Potential antiradical and alpha-glucosidase inhibitors from ecklonia maxima (osbeck) papenfuss</article-title><source>Food Chem.</source><year>2013</year><volume>141</volume><fpage>1412</fpage><lpage>1415</lpage><pub-id pub-id-type="doi">10.1016/j.foodchem.2013.04.019</pub-id><?supplied-pmid 23790932?><pub-id pub-id-type="pmid">23790932</pub-id></element-citation></ref><ref id="B125-marinedrugs-17-00464"><label>125.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Puspita</surname><given-names>M.</given-names></name><name><surname>Deniel</surname><given-names>M.</given-names></name><name><surname>Widowati</surname><given-names>I.</given-names></name><name><surname>Radjasa</surname><given-names>O.</given-names></name><name><surname>Douzenel</surname><given-names>P.</given-names></name><name><surname>Bedoux</surname><given-names>G.</given-names></name><name><surname>Bourgougnon</surname><given-names>N.</given-names></name></person-group><article-title>Antioxidant and antibacterial activity of solid-liquid and enzyme-assisted extraction of phenolic compound from three species of tropical sargassum</article-title><source>IOP Conference Series: Earth and Environmental Science</source><publisher-name>IOP Publishing Ltd.</publisher-name><publisher-loc>Bali, Indonesia</publisher-loc><year>2017</year><fpage>012057</fpage></element-citation></ref><ref id="B126-marinedrugs-17-00464"><label>126.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khan</surname><given-names>A.</given-names></name><name><surname>Uddin</surname><given-names>N.</given-names></name><name><surname>Khaliq</surname><given-names>S.</given-names></name><name><surname>Nawaz</surname><given-names>S.</given-names></name><name><surname>Rasheed</surname><given-names>M.</given-names></name><name><surname>Dar</surname><given-names>A.</given-names></name><name><surname>Hanif</surname><given-names>M.</given-names></name><name><surname>Siddiqui</surname><given-names>P.J.A.</given-names></name></person-group><article-title>Brown seaweeds administration generate psychotherapeutic response associated with brain norepinephrine modulation in rats</article-title><source>J. Pharm. Phytother.</source><year>2017</year><volume>9</volume><fpage>11</fpage><lpage>18</lpage></element-citation></ref><ref id="B127-marinedrugs-17-00464"><label>127.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grosso</surname><given-names>C.</given-names></name><name><surname>Andrade</surname><given-names>P.</given-names></name><name><surname>Valentao</surname><given-names>P.</given-names></name><name><surname>Mouga</surname><given-names>T.</given-names></name><name><surname>J&#x000e4;ger</surname><given-names>A.</given-names></name></person-group><article-title>Seaweeds: New source of mao-a inhibiting compounds</article-title><source>Planta Med.</source><year>2011</year><volume>77</volume><fpage>PM69</fpage><pub-id pub-id-type="doi">10.1055/s-0031-1282827</pub-id></element-citation></ref><ref id="B128-marinedrugs-17-00464"><label>128.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jacobs</surname><given-names>R.S.</given-names></name><name><surname>Culver</surname><given-names>P.</given-names></name><name><surname>Langdon</surname><given-names>R.</given-names></name><name><surname>O&#x02019;Brien</surname><given-names>T.</given-names></name><name><surname>White</surname><given-names>S.</given-names></name></person-group><article-title>Some pharmacological observations on marine natural products</article-title><source>Tetrahedron</source><year>1985</year><volume>41</volume><fpage>981</fpage><lpage>984</lpage><pub-id pub-id-type="doi">10.1016/S0040-4020(01)96465-8</pub-id></element-citation></ref><ref id="B129-marinedrugs-17-00464"><label>129.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nishibori</surname><given-names>N.</given-names></name><name><surname>Itoh</surname><given-names>M.</given-names></name><name><surname>Kashiwagi</surname><given-names>M.</given-names></name><name><surname>Arimochi</surname><given-names>H.</given-names></name><name><surname>Morita</surname><given-names>K.</given-names></name></person-group><article-title>In vitro cytotoxic effect of ethanol extract prepared from sporophyll of undaria pinnatifida on human colorectal cancer cells</article-title><source>Phytother. Res.</source><year>2012</year><volume>26</volume><fpage>191</fpage><lpage>196</lpage><pub-id pub-id-type="doi">10.1002/ptr.3527</pub-id><?supplied-pmid 21604310?><pub-id pub-id-type="pmid">21604310</pub-id></element-citation></ref><ref id="B130-marinedrugs-17-00464"><label>130.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dorta</surname><given-names>E.</given-names></name><name><surname>D&#x000ed;az-Marrero</surname><given-names>A.R.</given-names></name><name><surname>Cueto</surname><given-names>M.</given-names></name><name><surname>Darias</surname><given-names>J.</given-names></name></person-group><article-title>On the relative stereochemistry of atomaric acid and related compounds</article-title><source>Tetrahedron</source><year>2003</year><volume>59</volume><fpage>2059</fpage><lpage>2062</lpage><pub-id pub-id-type="doi">10.1016/S0040-4020(03)00215-1</pub-id></element-citation></ref><ref id="B131-marinedrugs-17-00464"><label>131.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Kalimuthu</surname><given-names>S.</given-names></name><name><surname>Kim</surname><given-names>S.-K.</given-names></name></person-group><article-title>Fucoidan, a sulfated polysaccharides from brown algae as therapeutic target for cancer</article-title><source>Handbook of Anticancer Drugs from Marine Origin</source><publisher-name>Springer</publisher-name><publisher-loc>Cham, Switzerland</publisher-loc><year>2015</year><fpage>145</fpage><lpage>164</lpage></element-citation></ref><ref id="B132-marinedrugs-17-00464"><label>132.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>X.</given-names></name><name><surname>Jiang</surname><given-names>X.</given-names></name><name><surname>Hwang</surname><given-names>H.</given-names></name><name><surname>Liu</surname><given-names>S.</given-names></name><name><surname>Guan</surname><given-names>H.</given-names></name></person-group><article-title>Antitumour activities of alginate-derived oligosaccharides and their sulphated substitution derivatives</article-title><source>Eur. J. Phycol.</source><year>2004</year><volume>39</volume><fpage>67</fpage><lpage>71</lpage><pub-id pub-id-type="doi">10.1080/09670260310001636695</pub-id></element-citation></ref><ref id="B133-marinedrugs-17-00464"><label>133.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ponnan</surname><given-names>A.</given-names></name><name><surname>Ramu</surname><given-names>K.</given-names></name><name><surname>Marudhamuthu</surname><given-names>M.</given-names></name><name><surname>Marimuthu</surname><given-names>R.</given-names></name><name><surname>Siva</surname><given-names>K.</given-names></name><name><surname>Kadarkarai</surname><given-names>M.</given-names></name></person-group><article-title>Antibacterial, antioxidant and anticancer properties of turbinaria conoides (j. Agardh) kuetz</article-title><source>Clin. Phytosci.</source><year>2017</year><volume>3</volume><fpage>5</fpage><pub-id pub-id-type="doi">10.1186/s40816-017-0042-y</pub-id></element-citation></ref><ref id="B134-marinedrugs-17-00464"><label>134.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>E.J.</given-names></name><name><surname>Park</surname><given-names>S.Y.</given-names></name><name><surname>Lee</surname><given-names>J.-Y.</given-names></name><name><surname>Park</surname><given-names>J.H.Y.</given-names></name></person-group><article-title>Fucoidan present in brown algae induces apoptosis of human colon cancer cells</article-title><source>BMC Gastroenterol.</source><year>2010</year><volume>10</volume><elocation-id>96</elocation-id><pub-id pub-id-type="doi">10.1186/1471-230X-10-96</pub-id><pub-id pub-id-type="pmid">20727207</pub-id></element-citation></ref><ref id="B135-marinedrugs-17-00464"><label>135.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fukuyama</surname><given-names>Y.</given-names></name><name><surname>Kodama</surname><given-names>M.</given-names></name><name><surname>Miura</surname><given-names>I.</given-names></name><name><surname>Kinzyo</surname><given-names>Z.</given-names></name><name><surname>Mori</surname><given-names>H.</given-names></name><name><surname>Nakayama</surname><given-names>Y.</given-names></name><name><surname>Takahashi</surname><given-names>M.</given-names></name></person-group><article-title>Anti-plasmin inhibitor. Vi.: Structure of phlorofucofuroeckol a, a novel phlorotannin with both dibenzo-1, 4-dioxin and dibenzofuran elements, from ecklonia kurome okamura</article-title><source>Chem. Pharmaceut. Bull.</source><year>1990</year><volume>38</volume><fpage>133</fpage><lpage>135</lpage><pub-id pub-id-type="doi">10.1248/cpb.38.133</pub-id><?supplied-pmid 2337936?><pub-id pub-id-type="pmid">2337936</pub-id></element-citation></ref><ref id="B136-marinedrugs-17-00464"><label>136.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>F.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Chang</surname><given-names>A.K.</given-names></name><name><surname>Liu</surname><given-names>B.</given-names></name><name><surname>Yang</surname><given-names>L.</given-names></name><name><surname>Li</surname><given-names>Q.</given-names></name><name><surname>Wang</surname><given-names>P.</given-names></name><name><surname>Zou</surname><given-names>X.</given-names></name></person-group><article-title>Fucoidan extract derived from undaria pinnatifida inhibits angiogenesis by human umbilical vein endothelial cells</article-title><source>Phytomedicine</source><year>2012</year><volume>19</volume><fpage>797</fpage><lpage>803</lpage><pub-id pub-id-type="doi">10.1016/j.phymed.2012.03.015</pub-id><?supplied-pmid 22510492?><pub-id pub-id-type="pmid">22510492</pub-id></element-citation></ref><ref id="B137-marinedrugs-17-00464"><label>137.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsubara</surname><given-names>K.</given-names></name><name><surname>Xue</surname><given-names>C.</given-names></name><name><surname>Zhao</surname><given-names>X.</given-names></name><name><surname>Mori</surname><given-names>M.</given-names></name><name><surname>Sugawara</surname><given-names>T.</given-names></name><name><surname>Hirata</surname><given-names>T.</given-names></name></person-group><article-title>Effects of middle molecular weight fucoidans on in vitro and ex vivo angiogenesis of endothelial cells</article-title><source>Int. J. Mol. Med.</source><year>2005</year><volume>15</volume><fpage>695</fpage><lpage>699</lpage><pub-id pub-id-type="doi">10.3892/ijmm.15.4.695</pub-id><?supplied-pmid 15754034?><pub-id pub-id-type="pmid">15754034</pub-id></element-citation></ref><ref id="B138-marinedrugs-17-00464"><label>138.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cumashi</surname><given-names>A.</given-names></name><name><surname>Ushakova</surname><given-names>N.A.</given-names></name><name><surname>Preobrazhenskaya</surname><given-names>M.E.</given-names></name><name><surname>D&#x02019;incecco</surname><given-names>A.</given-names></name><name><surname>Piccoli</surname><given-names>A.</given-names></name><name><surname>Totani</surname><given-names>L.</given-names></name><name><surname>Tinari</surname><given-names>N.</given-names></name><name><surname>Morozevich</surname><given-names>G.E.</given-names></name><name><surname>Berman</surname><given-names>A.E.</given-names></name><name><surname>Bilan</surname><given-names>M.I.</given-names></name></person-group><article-title>A comparative study of the anti-inflammatory, anticoagulant, antiangiogenic, and antiadhesive activities of nine different fucoidans from brown seaweeds</article-title><source>Glycobiology</source><year>2007</year><volume>17</volume><fpage>541</fpage><lpage>552</lpage><pub-id pub-id-type="doi">10.1093/glycob/cwm014</pub-id><?supplied-pmid 17296677?><pub-id pub-id-type="pmid">17296677</pub-id></element-citation></ref><ref id="B139-marinedrugs-17-00464"><label>139.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwak</surname><given-names>K.-W.</given-names></name><name><surname>Cho</surname><given-names>K.-S.</given-names></name><name><surname>Hahn</surname><given-names>O.-J.</given-names></name><name><surname>Lee</surname><given-names>K.-H.</given-names></name><name><surname>Lee</surname><given-names>B.-Y.</given-names></name><name><surname>Ko</surname><given-names>J.-J.</given-names></name><name><surname>Chung</surname><given-names>K.-H.</given-names></name></person-group><article-title>Biological effects of fucoidan isolated from fucus vesiculosus on thrombosis and vascular cells</article-title><source>Korean J. Hematol.</source><year>2010</year><volume>45</volume><fpage>51</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.5045/kjh.2010.45.1.51</pub-id><?supplied-pmid 21120163?><pub-id pub-id-type="pmid">21120163</pub-id></element-citation></ref><ref id="B140-marinedrugs-17-00464"><label>140.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahn</surname><given-names>M.-J.</given-names></name><name><surname>Yoon</surname><given-names>K.-D.</given-names></name><name><surname>Min</surname><given-names>S.-Y.</given-names></name><name><surname>Lee</surname><given-names>J.S.</given-names></name><name><surname>Kim</surname><given-names>J.H.</given-names></name><name><surname>Kim</surname><given-names>T.G.</given-names></name><name><surname>Kim</surname><given-names>S.H.</given-names></name><name><surname>Kim</surname><given-names>N.-G.</given-names></name><name><surname>Huh</surname><given-names>H.</given-names></name><name><surname>Kim</surname><given-names>J.</given-names></name></person-group><article-title>Inhibition of hiv-1 reverse transcriptase and protease by phlorotannins from the brown alga ecklonia cava</article-title><source>Biol. Pharmaceut. Bull.</source><year>2004</year><volume>27</volume><fpage>544</fpage><lpage>547</lpage><pub-id pub-id-type="doi">10.1248/bpb.27.544</pub-id><?supplied-pmid 15056863?><pub-id pub-id-type="pmid">15056863</pub-id></element-citation></ref><ref id="B141-marinedrugs-17-00464"><label>141.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hayashi</surname><given-names>K.</given-names></name><name><surname>Nakano</surname><given-names>T.</given-names></name><name><surname>Hashimoto</surname><given-names>M.</given-names></name><name><surname>Kanekiyo</surname><given-names>K.</given-names></name><name><surname>Hayashi</surname><given-names>T.</given-names></name></person-group><article-title>Defensive effects of a fucoidan from brown alga undaria pinnatifida against herpes simplex virus infection</article-title><source>Int. Immunopharmacol.</source><year>2008</year><volume>8</volume><fpage>109</fpage><lpage>116</lpage><pub-id pub-id-type="doi">10.1016/j.intimp.2007.10.017</pub-id><?supplied-pmid 18068106?><pub-id pub-id-type="pmid">18068106</pub-id></element-citation></ref><ref id="B142-marinedrugs-17-00464"><label>142.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Queiroz</surname><given-names>K.</given-names></name><name><surname>Medeiros</surname><given-names>V.</given-names></name><name><surname>Queiroz</surname><given-names>L.</given-names></name><name><surname>Abreu</surname><given-names>L.</given-names></name><name><surname>Rocha</surname><given-names>H.</given-names></name><name><surname>Ferreira</surname><given-names>C.</given-names></name><name><surname>Juca</surname><given-names>M.</given-names></name><name><surname>Aoyama</surname><given-names>H.</given-names></name><name><surname>Leite</surname><given-names>E.</given-names></name></person-group><article-title>Inhibition of reverse transcriptase activity of hiv by polysaccharides of brown algae</article-title><source>Biomed. Pharmacother.</source><year>2008</year><volume>62</volume><fpage>303</fpage><lpage>307</lpage><pub-id pub-id-type="doi">10.1016/j.biopha.2008.03.006</pub-id><?supplied-pmid 18455359?><pub-id pub-id-type="pmid">18455359</pub-id></element-citation></ref><ref id="B143-marinedrugs-17-00464"><label>143.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>B&#x000e9;ress</surname><given-names>A.</given-names></name><name><surname>Wassermann</surname><given-names>O.</given-names></name><name><surname>Bruhn</surname><given-names>T.</given-names></name><name><surname>B&#x000e9;ress</surname><given-names>L.</given-names></name><name><surname>Kraiselburd</surname><given-names>E.N.</given-names></name><name><surname>Gonazalez</surname><given-names>L.V.</given-names></name><name><surname>de Motta</surname><given-names>G.E.</given-names></name><name><surname>Chavez</surname><given-names>P.J.</given-names></name></person-group><article-title>A new procedure for the isolation of anti-hiv compounds (polysaccharides and polyphenols) from the marine alga fucus vesiculosus</article-title><source>J. Nat. Prod.</source><year>1996</year><volume>59</volume><fpage>552</fpage><pub-id pub-id-type="doi">10.1021/np960284u</pub-id></element-citation></ref><ref id="B144-marinedrugs-17-00464"><label>144.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dos Santos</surname><given-names>V.A.</given-names></name><name><surname>Leite</surname><given-names>K.M.</given-names></name><name><surname>da Costa Siqueira</surname><given-names>M.</given-names></name><name><surname>Regasini</surname><given-names>L.O.</given-names></name><name><surname>Martinez</surname><given-names>I.</given-names></name><name><surname>Nogueira</surname><given-names>C.T.</given-names></name><name><surname>Galuppo</surname><given-names>M.K.</given-names></name><name><surname>Stolf</surname><given-names>B.S.</given-names></name><name><surname>Pereira</surname><given-names>A.M.S.</given-names></name><name><surname>Cicarelli</surname><given-names>R.</given-names></name></person-group><article-title>Antiprotozoal activity of quinonemethide triterpenes from maytenus ilicifolia (celastraceae)</article-title><source>Molecules</source><year>2013</year><volume>18</volume><fpage>1053</fpage><lpage>1062</lpage><pub-id pub-id-type="doi">10.3390/molecules18011053</pub-id><pub-id pub-id-type="pmid">23322069</pub-id></element-citation></ref><ref id="B145-marinedrugs-17-00464"><label>145.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nara</surname><given-names>T.</given-names></name><name><surname>Kamei</surname><given-names>Y.</given-names></name><name><surname>Tsubouchi</surname><given-names>A.</given-names></name><name><surname>Annoura</surname><given-names>T.</given-names></name><name><surname>Hirota</surname><given-names>K.</given-names></name><name><surname>Iizumi</surname><given-names>K.</given-names></name><name><surname>Dohmoto</surname><given-names>Y.</given-names></name><name><surname>Ono</surname><given-names>T.</given-names></name><name><surname>Aoki</surname><given-names>T.</given-names></name></person-group><article-title>Inhibitory action of marine algae extracts on the trypanosoma cruzi dihydroorotate dehydrogenase activity and on the protozoan growth in mammalian cells</article-title><source>Parasitol. Int.</source><year>2005</year><volume>54</volume><fpage>59</fpage><lpage>64</lpage><pub-id pub-id-type="doi">10.1016/j.parint.2004.11.001</pub-id><?supplied-pmid 15710552?><pub-id pub-id-type="pmid">15710552</pub-id></element-citation></ref><ref id="B146-marinedrugs-17-00464"><label>146.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soares</surname><given-names>D.C.</given-names></name><name><surname>Calegari-Silva</surname><given-names>T.C.</given-names></name><name><surname>Lopes</surname><given-names>U.G.</given-names></name><name><surname>Teixeira</surname><given-names>V.L.</given-names></name><name><surname>de Palmer Paix&#x000e3;o</surname><given-names>I.C.</given-names></name><name><surname>Cirne-Santos</surname><given-names>C.</given-names></name><name><surname>Bou-Habib</surname><given-names>D.C.</given-names></name><name><surname>Saraiva</surname><given-names>E.M.</given-names></name></person-group><article-title>Dolabelladienetriol, a compound from dictyota pfaffii algae, inhibits the infection by leishmania amazonensis</article-title><source>PLoS Negl. Trop. Dis.</source><year>2012</year><volume>6</volume><elocation-id>e1787</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pntd.0001787</pub-id><?supplied-pmid 22970332?><pub-id pub-id-type="pmid">22970332</pub-id></element-citation></ref><ref id="B147-marinedrugs-17-00464"><label>147.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gall&#x000e9;</surname><given-names>J.-B.</given-names></name><name><surname>Attioua</surname><given-names>B.</given-names></name><name><surname>Kaiser</surname><given-names>M.</given-names></name><name><surname>Rusig</surname><given-names>A.-M.</given-names></name><name><surname>Lobstein</surname><given-names>A.</given-names></name><name><surname>Vonthron-S&#x000e9;n&#x000e9;cheau</surname><given-names>C.</given-names></name></person-group><article-title>Eleganolone, a diterpene from the french marine alga bifurcaria bifurcata inhibits growth of the human pathogens trypanosoma brucei and plasmodium falciparum</article-title><source>Mar. Drugs</source><year>2013</year><volume>11</volume><fpage>599</fpage><lpage>610</lpage><pub-id pub-id-type="doi">10.3390/md11030599</pub-id><?supplied-pmid 23442789?><pub-id pub-id-type="pmid">23442789</pub-id></element-citation></ref><ref id="B148-marinedrugs-17-00464"><label>148.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname><given-names>M.</given-names></name><name><surname>Lee</surname><given-names>H.-S.</given-names></name><name><surname>Kang</surname><given-names>I.-J.</given-names></name><name><surname>Won</surname><given-names>M.-H.</given-names></name><name><surname>You</surname><given-names>S.</given-names></name></person-group><article-title>Antioxidant properties of extract and fractions from enteromorpha prolifera, a type of green seaweed</article-title><source>Food Chem.</source><year>2011</year><volume>127</volume><fpage>999</fpage><lpage>1006</lpage><pub-id pub-id-type="doi">10.1016/j.foodchem.2011.01.072</pub-id><?supplied-pmid 25214089?><pub-id pub-id-type="pmid">25214089</pub-id></element-citation></ref><ref id="B149-marinedrugs-17-00464"><label>149.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lahaye</surname><given-names>M.</given-names></name><name><surname>Robic</surname><given-names>A.</given-names></name></person-group><article-title>Structure and functional properties of ulvan, a polysaccharide from green seaweeds</article-title><source>Biomacromolecules</source><year>2007</year><volume>8</volume><fpage>1765</fpage><lpage>1774</lpage><pub-id pub-id-type="doi">10.1021/bm061185q</pub-id><?supplied-pmid 17458931?><pub-id pub-id-type="pmid">17458931</pub-id></element-citation></ref><ref id="B150-marinedrugs-17-00464"><label>150.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qi</surname><given-names>H.</given-names></name><name><surname>Huang</surname><given-names>L.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Liu</surname><given-names>D.</given-names></name><name><surname>Zhang</surname><given-names>Q.</given-names></name><name><surname>Liu</surname><given-names>S.</given-names></name></person-group><article-title>Antihyperlipidemic activity of high sulfate content derivative of polysaccharide extracted from ulva pertusa (chlorophyta)</article-title><source>Carbohydr. Polym.</source><year>2012</year><volume>87</volume><fpage>1637</fpage><lpage>1640</lpage><pub-id pub-id-type="doi">10.1016/j.carbpol.2011.09.073</pub-id></element-citation></ref><ref id="B151-marinedrugs-17-00464"><label>151.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Hickey</surname><given-names>R.M.</given-names></name></person-group><article-title>Extraction and characterization of bioactive carbohydrates with health benefits from marine resources: Macro-and microalgae, cyanobacteria, and invertebrates</article-title><source>Marine Bioactive Compounds</source><publisher-name>Springer</publisher-name><publisher-loc>Boston, MA, USA</publisher-loc><year>2012</year><fpage>159</fpage><lpage>172</lpage></element-citation></ref><ref id="B152-marinedrugs-17-00464"><label>152.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pengzhan</surname><given-names>Y.</given-names></name><name><surname>Quanbin</surname><given-names>Z.</given-names></name><name><surname>Ning</surname><given-names>L.</given-names></name><name><surname>Zuhong</surname><given-names>X.</given-names></name><name><surname>Yanmei</surname><given-names>W.</given-names></name><name><surname>Zhi&#x02019;en</surname><given-names>L.</given-names></name></person-group><article-title>Polysaccharides from ulva pertusa (chlorophyta) and preliminary studies on their antihyperlipidemia activity</article-title><source>J. Appl. phYcol.</source><year>2003</year><volume>15</volume><fpage>21</fpage><lpage>27</lpage><pub-id pub-id-type="doi">10.1023/A:1022997622334</pub-id></element-citation></ref><ref id="B153-marinedrugs-17-00464"><label>153.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tabarsa</surname><given-names>M.</given-names></name><name><surname>Lee</surname><given-names>S.-J.</given-names></name><name><surname>You</surname><given-names>S.</given-names></name></person-group><article-title>Structural analysis of immunostimulating sulfated polysaccharides from ulva pertusa</article-title><source>Carbohydr. Res.</source><year>2012</year><volume>361</volume><fpage>141</fpage><lpage>147</lpage><pub-id pub-id-type="doi">10.1016/j.carres.2012.09.006</pub-id><?supplied-pmid 23023040?><pub-id pub-id-type="pmid">23023040</pub-id></element-citation></ref><ref id="B154-marinedrugs-17-00464"><label>154.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Celikler</surname><given-names>S.</given-names></name><name><surname>Tas</surname><given-names>S.</given-names></name><name><surname>Vatan</surname><given-names>O.</given-names></name><name><surname>Ziyanok-Ayvalik</surname><given-names>S.</given-names></name><name><surname>Yildiz</surname><given-names>G.</given-names></name><name><surname>Bilaloglu</surname><given-names>R.</given-names></name></person-group><article-title>Anti-hyperglycemic and antigenotoxic potential of ulva rigida ethanolic extract in the experimental diabetes mellitus</article-title><source>Food Chem. Toxicol.</source><year>2009</year><volume>47</volume><fpage>1837</fpage><lpage>1840</lpage><pub-id pub-id-type="doi">10.1016/j.fct.2009.04.039</pub-id><?supplied-pmid 19422873?><pub-id pub-id-type="pmid">19422873</pub-id></element-citation></ref><ref id="B155-marinedrugs-17-00464"><label>155.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sunilson</surname><given-names>J.A.J.</given-names></name><name><surname>Suraj</surname><given-names>R.</given-names></name><name><surname>Anandarajagopal</surname><given-names>K.</given-names></name><name><surname>Rejitha</surname><given-names>G.</given-names></name><name><surname>Vignesh</surname><given-names>M.</given-names></name><name><surname>Promwichit</surname><given-names>P.</given-names></name></person-group><article-title>Preliminary phytochemical analysis, elemental determination and antibacterial screening of codium decorticatum&#x02014;A marine green algae</article-title><source>Int. J. Biol. Chem.</source><year>2009</year><volume>3</volume><fpage>84</fpage><lpage>89</lpage></element-citation></ref><ref id="B156-marinedrugs-17-00464"><label>156.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khan</surname><given-names>M.N.</given-names></name><name><surname>Choi</surname><given-names>J.S.</given-names></name><name><surname>Lee</surname><given-names>M.C.</given-names></name><name><surname>Kim</surname><given-names>E.</given-names></name><name><surname>Nam</surname><given-names>T.J.</given-names></name><name><surname>Fujii</surname><given-names>H.</given-names></name><name><surname>Hong</surname><given-names>Y.K.</given-names></name></person-group><article-title>Anti-inflammatory activities of methanol extracts from various seaweed species</article-title><source>J. Environ. Biol.</source><year>2008</year><volume>29</volume><fpage>465</fpage><lpage>469</lpage><?supplied-pmid 19195382?><pub-id pub-id-type="pmid">19195382</pub-id></element-citation></ref><ref id="B157-marinedrugs-17-00464"><label>157.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>J.-B.</given-names></name><name><surname>Hayashi</surname><given-names>K.</given-names></name><name><surname>Maeda</surname><given-names>M.</given-names></name><name><surname>Hayashi</surname><given-names>T.</given-names></name></person-group><article-title>Antiherpetic activities of sulfated polysaccharides from green algae</article-title><source>Planta Med.</source><year>2004</year><volume>70</volume><fpage>813</fpage><lpage>817</lpage><pub-id pub-id-type="doi">10.1055/s-2004-827228</pub-id><?supplied-pmid 15386190?><pub-id pub-id-type="pmid">15386190</pub-id></element-citation></ref><ref id="B158-marinedrugs-17-00464"><label>158.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sato</surname><given-names>Y.</given-names></name><name><surname>Hirayama</surname><given-names>M.</given-names></name><name><surname>Morimoto</surname><given-names>K.</given-names></name><name><surname>Yamamoto</surname><given-names>N.</given-names></name><name><surname>Okuyama</surname><given-names>S.</given-names></name><name><surname>Hori</surname><given-names>K.</given-names></name></person-group><article-title>High mannose-binding lectin with preference for the cluster of &#x003b1;1&#x02013;2-mannose from the green alga boodlea coacta is a potent entry inhibitor of hiv-1 and influenza viruses</article-title><source>J. Biol. Chem.</source><year>2011</year><volume>286</volume><fpage>19446</fpage><lpage>19458</lpage><pub-id pub-id-type="doi">10.1074/jbc.M110.216655</pub-id><?supplied-pmid 21460211?><pub-id pub-id-type="pmid">21460211</pub-id></element-citation></ref><ref id="B159-marinedrugs-17-00464"><label>159.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>R.</given-names></name><name><surname>Paul</surname><given-names>V.J.</given-names></name><name><surname>Luesch</surname><given-names>H.</given-names></name></person-group><article-title>Seaweed extracts and unsaturated fatty acid constituents from the green alga ulva lactuca as activators of the cytoprotective nrf2&#x02013;are pathway</article-title><source>Free Rad. Biol. Med.</source><year>2013</year><volume>57</volume><fpage>141</fpage><lpage>153</lpage><pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2012.12.019</pub-id><?supplied-pmid 23291594?><pub-id pub-id-type="pmid">23291594</pub-id></element-citation></ref><ref id="B160-marinedrugs-17-00464"><label>160.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>R.</given-names></name><name><surname>Parihar</surname><given-names>P.</given-names></name><name><surname>Singh</surname><given-names>M.</given-names></name><name><surname>Bajguz</surname><given-names>A.</given-names></name><name><surname>Kumar</surname><given-names>J.</given-names></name><name><surname>Singh</surname><given-names>S.</given-names></name><name><surname>Singh</surname><given-names>V.P.</given-names></name><name><surname>Prasad</surname><given-names>S.M.</given-names></name></person-group><article-title>Uncovering potential applications of cyanobacteria and algal metabolites in biology, agriculture and medicine: Current status and future prospects</article-title><source>Front. Microbiol.</source><year>2017</year><volume>8</volume><pub-id pub-id-type="doi">10.3389/fmicb.2017.00515</pub-id><?supplied-pmid 28487674?><pub-id pub-id-type="pmid">28487674</pub-id></element-citation></ref><ref id="B161-marinedrugs-17-00464"><label>161.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhagavathy</surname><given-names>S.</given-names></name><name><surname>Sumathi</surname><given-names>P.</given-names></name><name><surname>Madhushree</surname><given-names>M.</given-names></name></person-group><article-title>Antimutagenic assay of carotenoids from green algae chlorococcum humicola using salmonella typhimurium ta98, ta100 and ta102</article-title><source>Asian Pacif. J. Trop. Dis.</source><year>2011</year><volume>1</volume><fpage>308</fpage><lpage>316</lpage><pub-id pub-id-type="doi">10.1016/S2222-1808(11)60073-X</pub-id></element-citation></ref><ref id="B162-marinedrugs-17-00464"><label>162.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ganesan</surname><given-names>P.</given-names></name><name><surname>Noda</surname><given-names>K.</given-names></name><name><surname>Manabe</surname><given-names>Y.</given-names></name><name><surname>Ohkubo</surname><given-names>T.</given-names></name><name><surname>Tanaka</surname><given-names>Y.</given-names></name><name><surname>Maoka</surname><given-names>T.</given-names></name><name><surname>Sugawara</surname><given-names>T.</given-names></name><name><surname>Hirata</surname><given-names>T.</given-names></name></person-group><article-title>Siphonaxanthin, a marine carotenoid from green algae, effectively induces apoptosis in human leukemia (hl-60) cells</article-title><source>Biochim. Biophys. Acta (BBA)-Gen. Subj.</source><year>2011</year><volume>1810</volume><fpage>497</fpage><lpage>503</lpage><pub-id pub-id-type="doi">10.1016/j.bbagen.2011.02.008</pub-id><?supplied-pmid 21371530?><pub-id pub-id-type="pmid">21371530</pub-id></element-citation></ref><ref id="B163-marinedrugs-17-00464"><label>163.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ganesan</surname><given-names>P.</given-names></name><name><surname>Matsubara</surname><given-names>K.</given-names></name><name><surname>Ohkubo</surname><given-names>T.</given-names></name><name><surname>Tanaka</surname><given-names>Y.</given-names></name><name><surname>Noda</surname><given-names>K.</given-names></name><name><surname>Sugawara</surname><given-names>T.</given-names></name><name><surname>Hirata</surname><given-names>T.</given-names></name></person-group><article-title>Anti-angiogenic effect of siphonaxanthin from green alga, codium fragile</article-title><source>Phytomedicine</source><year>2010</year><volume>17</volume><fpage>1140</fpage><lpage>1144</lpage><pub-id pub-id-type="doi">10.1016/j.phymed.2010.05.005</pub-id><?supplied-pmid 20637577?><pub-id pub-id-type="pmid">20637577</pub-id></element-citation></ref><ref id="B164-marinedrugs-17-00464"><label>164.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Selvin</surname><given-names>J.</given-names></name><name><surname>Lipton</surname><given-names>A.P.</given-names></name></person-group><article-title>Biopotentials of ulva fasciata and hypnea musciformis collected from the peninsular coast of india</article-title><source>J. Mar. Sci. Technol.</source><year>2004</year><volume>12</volume><fpage>1</fpage><lpage>6</lpage></element-citation></ref><ref id="B165-marinedrugs-17-00464"><label>165.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yuvaraj</surname><given-names>N.</given-names></name><name><surname>Kanmani</surname><given-names>P.</given-names></name><name><surname>Satishkumar</surname><given-names>R.</given-names></name><name><surname>Paari</surname><given-names>K.</given-names></name><name><surname>Pattukumar</surname><given-names>V.</given-names></name><name><surname>Arul</surname><given-names>V.</given-names></name></person-group><article-title>Extraction, purification and partial characterization of cladophora glomerata against multidrug resistant human pathogen acinetobacter baumannii and fish pathogens</article-title><source>World J. Fish Mar. Sci.</source><year>2011</year><volume>3</volume><fpage>51</fpage><lpage>57</lpage></element-citation></ref><ref id="B166-marinedrugs-17-00464"><label>166.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smyrniotopoulos</surname><given-names>V.</given-names></name><name><surname>Abatis</surname><given-names>D.</given-names></name><name><surname>Tziveleka</surname><given-names>L.-A.</given-names></name><name><surname>Tsitsimpikou</surname><given-names>C.</given-names></name><name><surname>Roussis</surname><given-names>V.</given-names></name><name><surname>Loukis</surname><given-names>A.</given-names></name><name><surname>Vagias</surname><given-names>C.</given-names></name></person-group><article-title>Acetylene sesquiterpenoid esters from the green alga caulerpa prolifera</article-title><source>J. Nat. Prod.</source><year>2003</year><volume>66</volume><fpage>21</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1021/np0202529</pub-id><?supplied-pmid 12542338?><pub-id pub-id-type="pmid">12542338</pub-id></element-citation></ref><ref id="B167-marinedrugs-17-00464"><label>167.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deacon-Smith</surname><given-names>R.</given-names></name><name><surname>Lee-Potter</surname><given-names>J.</given-names></name><name><surname>Rogers</surname><given-names>D.</given-names></name></person-group><article-title>Anticoagulant activity in extracts of british marine algae</article-title><source>Bot. Mar.</source><year>1985</year><volume>28</volume><fpage>333</fpage><lpage>338</lpage><pub-id pub-id-type="doi">10.1515/botm.1985.28.8.333</pub-id></element-citation></ref><ref id="B168-marinedrugs-17-00464"><label>168.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsubara</surname><given-names>K.</given-names></name><name><surname>Matsuura</surname><given-names>Y.</given-names></name><name><surname>Hori</surname><given-names>K.</given-names></name><name><surname>Miyazawa</surname><given-names>K.</given-names></name></person-group><article-title>An anticoagulant proteoglycan from the marine green alga, codium pugniformis</article-title><source>J. Appl. Phycol.</source><year>2000</year><volume>12</volume><fpage>9</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1023/A:1008174115350</pub-id></element-citation></ref><ref id="B169-marinedrugs-17-00464"><label>169.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maeda</surname><given-names>M.</given-names></name><name><surname>Uehara</surname><given-names>T.</given-names></name><name><surname>Harada</surname><given-names>N.</given-names></name><name><surname>Sekiguchi</surname><given-names>M.</given-names></name><name><surname>Hiraoka</surname><given-names>A.</given-names></name></person-group><article-title>Heparinoid-active sulphated polysaccharides frommonostroma nitidum and their distribution in the chlorophyta</article-title><source>Phytochemistry</source><year>1991</year><volume>30</volume><fpage>3611</fpage><lpage>3614</lpage><pub-id pub-id-type="doi">10.1016/0031-9422(91)80076-D</pub-id></element-citation></ref><ref id="B170-marinedrugs-17-00464"><label>170.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Synytsya</surname><given-names>A.</given-names></name><name><surname>Choi</surname><given-names>D.J.</given-names></name><name><surname>Pohl</surname><given-names>R.</given-names></name><name><surname>Na</surname><given-names>Y.S.</given-names></name><name><surname>Capek</surname><given-names>P.</given-names></name><name><surname>Lattov&#x000e1;</surname><given-names>E.</given-names></name><name><surname>Taubner</surname><given-names>T.</given-names></name><name><surname>Choi</surname><given-names>J.W.</given-names></name><name><surname>Lee</surname><given-names>C.W.</given-names></name><name><surname>Park</surname><given-names>J.K.</given-names></name></person-group><article-title>Structural features and anti-coagulant activity of the sulphated polysaccharide sps-cf from a green alga capsosiphon fulvescens</article-title><source>Mar. Biotechnol.</source><year>2015</year><volume>17</volume><fpage>718</fpage><lpage>735</lpage><pub-id pub-id-type="doi">10.1007/s10126-015-9643-y</pub-id><pub-id pub-id-type="pmid">26337523</pub-id></element-citation></ref><ref id="B171-marinedrugs-17-00464"><label>171.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patel</surname><given-names>S.</given-names></name></person-group><article-title>Therapeutic importance of sulfated polysaccharides from seaweeds: Updating the recent findings</article-title><source>3 Biotech</source><year>2012</year><volume>2</volume><fpage>171</fpage><lpage>185</lpage><pub-id pub-id-type="doi">10.1007/s13205-012-0061-9</pub-id></element-citation></ref><ref id="B172-marinedrugs-17-00464"><label>172.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Watanabe</surname><given-names>Y.</given-names></name><name><surname>Naganuma</surname><given-names>T.</given-names></name><name><surname>Ogawa</surname><given-names>T.</given-names></name><name><surname>Muramoto</surname><given-names>K.</given-names></name></person-group><article-title>Lectins of marine origin and their clinical applications</article-title><source>Antitumor Potential and Other Emerging Medicinal Properties of Natural Compounds</source><publisher-name>Springer</publisher-name><publisher-loc>New York, NY, USA</publisher-loc><year>2013</year><fpage>33</fpage><lpage>54</lpage></element-citation></ref></ref-list></back><floats-group><fig id="marinedrugs-17-00464-f001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Chemical structure of marine natural compounds isolated from marine microorganisms. (A) Lynamicin E; (B) Lynamicin B; (C) Lynamicin A; (D) Lynamicin D; (E) Dehydroxychlorofusarielin B; (F) Aquastatin A; (G) Thiocoraline; (H) Pestalotiopsone F; (I) Anhydrofulvic acid; (J) Citromycetin.</p></caption><graphic xlink:href="marinedrugs-17-00464-g001"/></fig><fig id="marinedrugs-17-00464-f002" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Chemical Structure of marine natural compounds isolated from marine microalgae. (A) Cryptophycin; (B) Ambiguine H isonitriles; (C) Noscomin; (D) Dolastatin 10.</p></caption><graphic xlink:href="marinedrugs-17-00464-g002"/></fig><fig id="marinedrugs-17-00464-f003" orientation="portrait" position="float"><label>Figure 3</label><caption><p>Chemical Structure of marine natural compounds isolated from marine microalgae. (A) Tolytoxin; (B) Toyocamycin; (C) Dolastatin 13; (D) Lyngbyastatin 7; (E) Majusculoic acid; (F) Nostodione A.; (G) Tjipanazole D.</p></caption><graphic xlink:href="marinedrugs-17-00464-g003"/></fig><fig id="marinedrugs-17-00464-f004" orientation="portrait" position="float"><label>Figure 4</label><caption><p>Chemical structure of marine natural compounds isolated from marine macroalgae. (A) Agar; (B) Alpha-Allokainic acid; (C) Stypoquinonic acid; (D) Siphonaxanthin; (E) Lutein; (F) Fucoidan; (G) 8,8&#x02019;-Bieckol; (H) Caulerpenyne; (<bold>I</bold>) Phlorofucofuroeckol A; (<bold>J</bold>) Sodium alginate.</p></caption><graphic xlink:href="marinedrugs-17-00464-g004"/></fig><table-wrap id="marinedrugs-17-00464-t001" orientation="portrait" position="float"><object-id pub-id-type="pii">marinedrugs-17-00464-t001_Table 1</object-id><label>Table 1</label><caption><p>Structure and biological activity of some novel marine microorganisms&#x02019; natural compounds.</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="6" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Marine Microorganisms (Bacteria, Fungi, and Cyanobacteria)</th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Compound</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Chemical Structure</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Source/Species</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Biological Activity</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mechanism of Action</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">References</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Salinosporamide A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><inline-graphic xlink:href="marinedrugs-17-00464-i001.jpg"/></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Actinomycete/<italic>Salinispora tropica</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Treatment of multiple myeloma (anticancer); antimalarial</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibits proteasome activity by covalently modifying the threonine residue of the active site of the 20S proteasome</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B20-marinedrugs-17-00464" ref-type="bibr">20</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Plinabulin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><inline-graphic xlink:href="marinedrugs-17-00464-i002.jpg"/></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fungi/<italic>Aspergillus</italic> sp.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Treatment of solid tumors and lymphomas</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Depolymerizes microtubules in A549 human lung carcinoma cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B21-marinedrugs-17-00464" ref-type="bibr">21</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Alternaramide</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><inline-graphic xlink:href="marinedrugs-17-00464-i003.jpg"/></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ascomycete fungi/<italic>Alternaria</italic> sp.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anti-inflammatory</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibits inflammatory mediator expression through TLR4-MyD88-mediated inhibition of NF-&#x0043a;B and MAPK pathway signaling in lipopolysaccharide-stimulated RAW264.7 and BV2 cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B22-marinedrugs-17-00464" ref-type="bibr">22</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Macrolactin S</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><inline-graphic xlink:href="marinedrugs-17-00464-i004.jpg"/></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bacterium/<italic>Bacillus</italic> sp.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antibacterial</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">FabG inhibition agent</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B23-marinedrugs-17-00464" ref-type="bibr">23</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Oxaline</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><inline-graphic xlink:href="marinedrugs-17-00464-i005.jpg"/></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ascomycete fungi/<italic>Penicillium</italic> sp.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antitumor</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibits cell proliferation and induces cell cycle arrest at the G<sub>2</sub>/M phase in Jurkat cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B24-marinedrugs-17-00464" ref-type="bibr">24</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Grassystatin C</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><inline-graphic xlink:href="marinedrugs-17-00464-i006.jpg"/></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tropical cyanobacteria/<italic>Okeania lorea</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cathepsin inhibition</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Potent cathepsin E inhibitor that reduces antigen presentation</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B25-marinedrugs-17-00464" ref-type="bibr">25</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Palmyramide A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><inline-graphic xlink:href="marinedrugs-17-00464-i007.jpg"/></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Filamentous cyanobacteria/<italic>Moorea producens</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antitumor</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sodium channel blocking activity in neuro-2a cells and cytotoxic activity in H-460 human lung carcinoma cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B26-marinedrugs-17-00464" ref-type="bibr">26</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Coibamide A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><inline-graphic xlink:href="marinedrugs-17-00464-i008.jpg"/></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pantropical cyanobacteria/<italic>Caldora penicillata</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antitumor cytotoxicity</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibits VEGFA/VEGFR2 expression and suppresses tumor growth in glioblastoma xenografts</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B27-marinedrugs-17-00464" ref-type="bibr">27</xref>,<xref rid="B28-marinedrugs-17-00464" ref-type="bibr">28</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hectochlorin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><inline-graphic xlink:href="marinedrugs-17-00464-i009.jpg"/></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cyanobacterium/<italic>Lyngbya majusculea</italic> JHB</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxin, antifungal</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibits the growth of human cell lines by hyper-polymerization of actin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B29-marinedrugs-17-00464" ref-type="bibr">29</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pompanopeptin A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><inline-graphic xlink:href="marinedrugs-17-00464-i010.jpg"/></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cyanobacterium/<italic>Lyngbya confervoides</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Trypsin inhibitor</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibits trypsin with an IC<sub>50</sub> value of 2.4 &#x003bc;M; selectivity is conferred by the arginine residue</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B30-marinedrugs-17-00464" ref-type="bibr">30</xref>]</td></tr></tbody></table></table-wrap><table-wrap id="marinedrugs-17-00464-t002" orientation="portrait" position="float"><object-id pub-id-type="pii">marinedrugs-17-00464-t002_Table 2</object-id><label>Table 2</label><caption><p>Structure and biological activity of some novel marine seaweeds&#x02019; natural compounds.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Natural Compound</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Chemical Structure</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Species</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Biological Activity</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Mechanism of action</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">References</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sulfated galactan</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><inline-graphic xlink:href="marinedrugs-17-00464-i011.jpg"/></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Green alga/<italic>Codium fragile</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Immunostimulating effects via activation of macrophages</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Stimulates the production of nitric oxide by inducing iNOS at mRNA and protein levels and induces the expression of several cytokine mRNA, such as IL-1&#x003b2;, IL-6, IL-10, and TNF-&#x003b1;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B71-marinedrugs-17-00464" ref-type="bibr">71</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Caulerpin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><inline-graphic xlink:href="marinedrugs-17-00464-i012.jpg"/></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Green alga/<italic>Caulerpa racemosa</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anti-inflammatory and antinociceptive</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibits capsaicin-induced ear edema model and significantly reduces the number of recruited cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B72-marinedrugs-17-00464" ref-type="bibr">72</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pheophytin A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><inline-graphic xlink:href="marinedrugs-17-00464-i013.jpg"/></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Green alga/<italic>Enteromorpha prolifera</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anti-inflammatory</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Exhibits significant suppression of TPA-induced inflammatory reaction, such as edema formation in BALB/c mouse ear</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B73-marinedrugs-17-00464" ref-type="bibr">73</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cymopols</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><inline-graphic xlink:href="marinedrugs-17-00464-i014.jpg"/></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Green alga/<italic>Cymopolia barbata</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antimutagenic</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibits the mutagenicity of 2-aminoanthracene in T-98 strain. Behaves as a metabolic activator</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B74-marinedrugs-17-00464" ref-type="bibr">74</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Caulerpenyne</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><inline-graphic xlink:href="marinedrugs-17-00464-i015.jpg"/></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Green alga/<italic>Caulerpa taxifolia</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anticancer</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Shows cytotoxicity in cultured cell lines, such as KB cells and hamster fibroblasts</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B75-marinedrugs-17-00464" ref-type="bibr">75</xref>,<xref rid="B76-marinedrugs-17-00464" ref-type="bibr">76</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fucoxanthin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><inline-graphic xlink:href="marinedrugs-17-00464-i016.jpg"/></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Brown algae</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antidiabetic and antiobesity</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Suppresses McP-1, promotes adrb3 and gluT4 expression, and induces uncoupling protein 1 expression in white adipose tissue (WAT) mitochondria, leading to oxidation of fatty acids and heat production in WAT</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B77-marinedrugs-17-00464" ref-type="bibr">77</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Dieckol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><inline-graphic xlink:href="marinedrugs-17-00464-i017.jpg"/></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Brown alga/<italic>Ecklonia cava</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anti-inflammatory and neuroprotective agent</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Suppresses LPS-induced production of nitric oxide (NO) and prostaglandin E<sub>2</sub> (PGE<sub>2</sub>) and the expression of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) in murine BV2 microglia</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B78-marinedrugs-17-00464" ref-type="bibr">78</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Spiralisone A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><inline-graphic xlink:href="marinedrugs-17-00464-i018.jpg"/></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Brown alga/<italic>Zonaria spiralis</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Kinase inhibitor and antibacterial</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Shows inhibitory activity against neurodegenerative diseases targeting CDK5/p25, CK1&#x003b4;, and GSK3&#x003b2; kinases. Inhibits the Gram-positive bacteria <italic>Bacillus subtilis</italic> (ATCC 6051 and 6633)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B79-marinedrugs-17-00464" ref-type="bibr">79</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sargaquinoic acid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><inline-graphic xlink:href="marinedrugs-17-00464-i019.jpg"/></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Brown alga/<italic>Sargassum sagamianum</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AChE inhibitor</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibits acetylcholinesterase activity</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B80-marinedrugs-17-00464" ref-type="bibr">80</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Phorbasterone B</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><inline-graphic xlink:href="marinedrugs-17-00464-i020.jpg"/></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Red seaweed</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antimicrobial</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Exhibits antimicrobial activity against <italic>Bacillus cereus, Staphylococcus aureus, Streptococcus pneumoniae</italic>, and <italic>Candida albicans</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B81-marinedrugs-17-00464" ref-type="bibr">81</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Azocinyl- morpholinone</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><inline-graphic xlink:href="marinedrugs-17-00464-i021.jpg"/></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Red seaweed/<italic>Gracilaria opuntia</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antioxidant, anti-inflammatory by inhibiting cyclooxygenase and lipoxygenase</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Azocinyl morpholinone significantly mitigated the carrageenan-induced paw edema</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B82-marinedrugs-17-00464" ref-type="bibr">82</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(5Z)-4-bromo-5-(bromo-methylene)-3-butyl-2(5H)-furanone</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><inline-graphic xlink:href="marinedrugs-17-00464-i022.jpg"/></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Red seaweed/<italic>Delisea pulchra</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antifouling agent</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibits microbial-induced corrosion related to Gram-positive bacteria</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B83-marinedrugs-17-00464" ref-type="bibr">83</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Kahalalide A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><inline-graphic xlink:href="marinedrugs-17-00464-i023.jpg"/></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Red seaweed/<italic>Bryopsis</italic> sp.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antibacterial agent</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Shows in vitro<break/>activity against<break/><italic>Mycobacterium tuberculosis</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B84-marinedrugs-17-00464" ref-type="bibr">84</xref>,<xref rid="B85-marinedrugs-17-00464" ref-type="bibr">85</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Kahalalide F</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><inline-graphic xlink:href="marinedrugs-17-00464-i024.jpg"/></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Red seaweed/<italic>Bryopsis</italic> sp.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antibacterial and anti-HIV agent</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Shows antibacterial activity against <italic>M. tuberculosis</italic> and proposed for the treatment of lung cancer</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B84-marinedrugs-17-00464" ref-type="bibr">84</xref>,<xref rid="B85-marinedrugs-17-00464" ref-type="bibr">85</xref>]</td></tr></tbody></table></table-wrap></floats-group></article>